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Abstract
Many biochemical processes in which DNA and other nucleic acids participate
are central to functions in both living cells and in molecular biology assays. While many
compounds have been used to regulate the activity of DNA, these strategies are limited
to the aqueous-based diffusion of the activator to the target DNA molecule. An
improvement to the induction of DNA bioactivity is to move to a light-based modulation.
This research demonstrates a light-based technique using a photo-cleavable cage
compound to transiently inactivate DNA hybridization. Function can be restored with
exposure to near-UV light, allowing for temporal control of DNA oligonucleotide (ODN)
activity. This method has demonstrated the control of hybridization in molecular biology
assays, and provides the framework for in vivo experimentation. A similar lightactivated strategy has been shown useful in controlling expression of plasmid
transgenes (Monroe 1999). By adapting this method to DNA oligonucleotides (ODNs),
we have partially blocked hybridization with the cage compound (1-(4,5-dimethoxy-2nitrophenyl)ethyl ester (DMNPE) for both phosphodiester and phosphorothioate DNA
ODNs. The production and purification of DMNPE-caged DNA ODNs yields products
with similar spectrophotometric properties to caged plasmids. In hybridization studies,
20-mer (20 base long) caged DNA ODNs were hybridized with complementary 30-mer
molecular beacon probes, and fluorescence measurements were used to assess
hybridization of native (non-caged), caged, and caged-light-exposed ODNs.
Developments of the molecular beacon assays were studied to improve sensitivity of
the assay to caged and caged-flashed ODN hybridization control. Results demonstrated
that hybridization can be blocked and subsequently restored by light through the

ix

attachment of the DMNPE cage compound, and were further characterized with gel
electrophoresis assays. ODN hybridization was restricted to as little as 2% when
compared to native (non-caged) ODNs and restored to up to nearly 80% of the native
(non-caged) ODN hybridization activity levels. Additional studies on adduction,
purification, and characterization of the DMNPE-caged ODNs were performed to
optimize their production and efficacy in controlling hybridization. These results suggest
that this light-based technology can be used as a tool for the spatial and temporal
regulation of hybridization-based DNA bioactivity, including applications with antisense
ODNs as a form of controlled gene therapy.

x

Chapter 1
Introduction
The use of nucleic acids as tools in molecular engineering and gene therapy has
rapidly increased over recent years. Nucleic acids have been developed into powerful
tools to achieve many goals never before thought possible. Recently, much of the
focus on nucleic acids has been for their use as forms of gene therapy. Recent studies
have focused on the use of nucleic acids as a method for treatment for numerous forms
of disease (Gewirtz 2001; Opalinska 2002). When expression of genetic therapies is
targeted to desired tissues, the treatment is safer and more efficient.
The overall purpose of this research is to develop a method to reversibly control
the bioactivity of DNA oligonucleotides to spatially and temporally control gene
expression. Our hypothesis is that DNA oligonucleotide hybridization with a
complimentary target can be controlled through the use of photo-cleavable cage
compounds, such as 1-(4,5-dimethoxy-2-nitrophenyl)ethyl ester (DMNPE) until the cage
compound is photo-cleaved from the oligonucleotides by exposure to near-UV light Our
study focuses on the development of this control method in vitro for DNA
oligonucleotides with normal phosphodiester backbones as well as those with sulfurmodified (phosphorothioate) backbones. We aim to demonstrate that reversible caging
of the oligonucleotides is possible and efficient through the of use several qualitative
and quantitative in vitro analyses. We also propose to utilize temperature-varying
assays to help provide more sensitive techniques for analysis of the ability to control
hybridization of DNA oligonucleotides through caging. This study is intended to provide
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a basis for further in vivo studies of spatial and temporal control of DNA oligonucleotide
hybridization activity through the use of cage compounds.
Cage Compounds
One specific technique being employed to achieve control of nucleic acid
hybridization, and the main focus of this research, is the use of photo-cleavable cage
compounds. These molecules are compounds that bind to their target with a covalent,
yet photo-cleavable bond. Once attached to its target, the cage compound prevents the
effector molecule from being reactive, until a time at which it is photo-cleaved and the
effector molecule is once again reactive (McCray 1989). It is important to note that
these compounds do not literally encompass or form a cage around the effector
molecule. In reality, these molecules hinder the reactive abilities of their target by
reducing the structural reformation of the effector molecule (McCray 1989; Pelliccioli
2002). Initial studies of cage compounds within biological systems focused on the
ability to render ATP biologically inert, and then restore it to a bioactive form (Kaplan
1978). This task was achieved by attaching the cage compound 1-(2-nitrophenyl) ethyl
(NPE) to the γ-phosphate of ATP. They detected the efficacy of this strategy by sodium
efflux measurements. The ATP was rendered inactive until exposed to 340 nm light, at
which point consumption of the ATP was restored. A similar basic mechanism for
caged ATP can be seen in Figure 1.1 where the cage compound used is 1-(4,5dimethoxy-2-nitrophenyl)diazoethane (DMNPE). It should be noted that DMNPE
contains two methoxy groups attached to the 4’ and 5’ carbon atoms on the benzyl ring,
and is photo-cleaved by 365 nm light (MolecularProbes 1996).

2

NH 2
N

H 3CO

CH3 O O O
N
O P O P O P O CH2
O
O - O- O-

H 3CO

NO2

OH

NH 2

N
N
N

OH

hv

-O

365 nm

DMNPE-Caged ATP
(biologically inert)

N
O O O
P O P O P O CH2
O
O- O - O OH

N
CH3

N

+

O

H 3CO
H 3CO

NO

OH

bioactive ATP

released cage
(DMNAP)

Figure 1.1. Photolysis of ATP caged with a caged compound, DMNPE.
Since the initial experiments with ATP, numerous studies have focused on the
use of cage compounds to control bioactivity across several platforms. Time course
studies of rapid responses within cells have been greatly helped by the use of cage
compounds (McCray 1980; Gee 1998; Choi 2003). Biologically inactive ATP can be
introduced into cells in a biological inert form. Upon exposure to light at rapid pulses,
restoration of bioactivity can be achieved and the rate at which the ATP is consumed
can be controlled and monitored. In this and many other applications, the advantages of
using photo-protected or caged species over conventional methods for substrate
release are that the caged species can be dispersed throughout the biological target
without eliciting the species’ normal bioactivity, the concentration and spatial distribution
can be controlled, and finally, the temporal release can be varied from seconds to
nanoseconds (Givens 1998). There have been many studies that have shown control
of other biological processes using cage compounds within cellular studies. These have
included transport of proteins, and effects on biological membranes, as well as
relaxation of muscle fibers (Patton 1991; Pirrung 1994; Ishihara 1997; Lee 1997). The
development of cage compounds for use within biological systems is greatly on the rise.
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The use of caged compounds is also being further developed for aiding in control
of gene expression and its effects on organisms. Areas of focus for the control of gene
expression can be seen with the production of proteins (Monroe 1999; Ando 2001) and
bioactivity of hormones (Dorai 1997; Lim 2002; Garcia-Fernandez 2003). Several
possible techniques are being studied to block DNA transcription and those that prevent
translation of mRNA through degradation (Monroe; Ando 2001; Harborth 2003).
As the utilization of cage compounds has expanded, the structures of caging
compounds have been developed based on their specific intended uses. Many are
benzyl rings or derivatives with strong leaving groups, commonly bromine, chlorine, or
diazonium, each with specific functions and preferred replacements. Some examples of
caging compounds are single benzyl rings, such as 1-(2-nitrophenyl)-diazoethane
(NPE) and DMNPE, while others are multi-ring compounds such as 6-bromo-7hydroxycoumarin-4-ylmethly (BHC) (Furuta 1999; reviewed by Pelliccioli 2002). In the
case of DMNPE, this cage compound can be photolyzed by photons of wavelength 365
nm (Monroe 1999) similar to that of BHC (Furuta 1999), which differs from those of NPE
at 340 nm (Walker 1988). The longer wavelength of light is beneficial for
photoactivation in cells and tissues due to less photodamage.
There are few descriptions of applying caging chemistry to nucleic acids to
temporally and spatially control function. Cage compounds have been used in the
caging of nucleotide analogs (Walker 1988), in the synthesis of bio-chip
oligonucleotides (McGall 1996), in studies of the kinetics of DNA repair (Meldrum 1990;
Meldrum 1998; Ordoukhanian 2000), and as protecting groups during DNA synthesis
(Alvarez 1999). Cage groups have also been shown to control an oligonucleotide
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Figure 1. 2 Proposed site of
DMNPE adduction to DNA
ODN.

activities by including caged adenosine within synthesized RNA oligonucleotides
(Chaulk 1998; Chaulk 2001).
Through the attachment of cage compounds, generation of translation and
transcription products such as proteins and enzymes can be brought to minimal or no
yield by preventing the nucleic acid from forming certain structural conformations.
Based on the previous studies of ATP, it is theorized that the attachment of the DMNPE
cage compound occurs along the phosphate backbone of the nucleic acid as seen in
Figure 1.2 to a protonated non-bridging oxygen of the phosphate backbone.
Attachment at this position is consistent with DMNPE’s attachment to other moieties
such as carboxylic acids and phosphates, or other weak oxy acids (Walker 1988).
In addition to controlling the kinetics of a particular molecular target, caging
affords the ability to restrict re-activation to a localized tissue of interest, as
demonstrated by the targeting of transgene expression by caging hormone inducers
(Cruz 2000; Lin 2002). Control of bioactivity through direct caging of nucleic acids has
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been demonstrated with plasmid DNA both in vitro and in vivo by controlling transgene
expression with light exposure (Monroe 1999). More recently, BHC caged mRNA was
microinjected into zebrafish embryos to induce expression of certain genes and study
the effect of their expression on developmental patterns (Ando 2001). This work has
shown that the use of BHC reacted with mRNA coding for green fluorescent protein
demonstrated a reduction in translational activity. Once illuminated by photons,
translational activity was restored (Ando 2003). This shows a trend to develop
increasingly efficient and effective caging compounds, which can be specifically
designed to work with complementing sequences of mRNA and DNA. We now present
a method for controlling the hybridization activity of short DNA ODNs through the
adduction and photo-cleavage cage compounds, thus allowing for spatial and temporal
control of ODN bioactivity.
Gene Therapy: Antisense
The use of cage compounds can be noted for its effectiveness in preventing
expression of DNA plasmids (Monroe 1999) and mRNA (Ando 2001), and current
studies are moving in the direction of performing further tests on other nucleic acids.
Both of the aforementioned studies focus on the use of cage compounds with antisense
therapy technologies. These compounds may be used with DNA to hybridize and alter
transcription (Monroe 1999) and mRNA to prevent translation (Dash 1987; Walder
1988; Liebhaber 1992; Vickers 2001; Sazani 2003), thus preventing or modifying protein
production. While traditional drugs and therapies focus on the breakdown or control of
proteins already produced, the antisense therapies focus on controlling the production
of the proteins on a genetic level (Christoffersen 1995; Koller 2000; Sun 2000; Steele
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2003). Antisense oligonucleotides have been studied for several years as treatments
for many diseases and genetic disorders (Berg 2002; Alvarez-Salas 2003; Hugle 2003).
Antisense therapy is based on the principles of genetic expression. Strands of
mRNA are transcribed from DNA, and are a copy of the “coding” or “sense” strand of
the gene. This main form of the therapy uses the complementary or “antisense” strand
of the target to hybridize the “sense”
strand and prevents production of the
protein by blocking or altering translation.
Another form of antisense therapy is the
use of modified ribozymes that are
catalytic RNA derivatives which are
sequence specific and are involved in
processes such as self-cleavage, ligation,
or splicing of mRNA (Kruger 1982;

Figure 1.3. Antisense oligonucleotide
mechanism through RNase H cleavage
of mRNA.

Buzayan 1986; Hutchins 1986; Symons
1987; Sharmeen 1988; Davies 1990).

RNAi is another antisense technique, which functions on the premise of the production
within cells of short interfering RNAs (siRNAs) that are effectors for targeted gene
silencing (Fire 1998; Caplen 2001; Elbashir 2001; Elbashir 2001; Bertrand 2002;
Miyagishi 2003).
One specific type of these oligonucleotides is known as antisense
oligodeoxynucleotides or antisense ODNs, and they are designed to hybridize with a
specific mRNA complement. These antisense ODNS work by hybridizing to their
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complementary or target mRNA through basic complimentary Watson-Crick basepairing (Paterson 1977). Upon hybridization with the target mRNA, translation can be
blocked through several mechanisms. These include prevention of the mRNA from
being processed through the ribosome (Liebhaber, Cash et al. 1992), modifying the
splicing of the mRNA (Sazani and Kole 2003), or an impairment of the polyadenylation
of the mRNA (Vickers 2001). The most common mechanism of preventing translation
through antisense ODNs is the activation of RNase-H enzyme, which will degrade the
mRNA when complexed with the antisense ODNs (Dash 1987; Walder 1988). Here,
antisense ODNs are very effective in that the RNase H does not break down the ODN,
and so they can continue to hybridize with more target mRNA. An example of this
mechanism can be seen in Figure 1.3. Modifications of the ODNs have become a
necessity in order to use them for in vivo treatments. Cellular defense mechanisms
have influenced the efficiency of these tools through degradation of the ODNs within the
cell by nucleases (Wickstrom 1986; Akhtar 1991). Modifications of the ODNs to
improve efficacy have mainly focused on backbone modifications (Chavany 1995;
Agrawal 1997; Summerton 1997; Summerton 1997; Schmajuk 1999) and base
modification (Kuwasaki 1996; Herdewijn 2000; Kimber 2003; Sazani and Kole 2003).
The most widely used modified DNA in antisense therapies is phosphorothioate ODNs,
which replaces a non-binding oxygen on the phosphate back-bone with a sulfur, as
shown in Figure 1.4. These modified ODNs have a much greater resistance to
digestion by nucleases, and so have advanced the use of antisense therapies
immensely. This modified oligonucleotide has been used with many gene therapy
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studies and treatments (Chavany 1995; Monia 1996; Butler 1997; de Smet 1999; Yu
2003).
These modified antisense ODNs are being used to help fight disease and several
are currently undergoing FDA approval. The first antisense treatment to get FDA
approval to date has been Formivirsen (Vitravene), which is a treatment for
cytomegalovirus (CMV) retinitis in people with AIDS and was developed by ISIS
Pharmaceuticals (Roehr 1998; de Smet 1999). Several other antisense therapies are
undergoing FDA approval that focus on combating diseases such as HIV, malignant
melanoma, B-cell lymphoma, colon cancer, and lung (Wong-Staal 1998; Amado 1999;
Coudert 2001; Cripps 2002; Morris 2002; Adjei 2003). Also, much of the research has
recently focused on control and
treatment of cancer. One pathway
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Figure 1.4. Phosphodiester ODN (left) and
phosphorothioate modified ODN (right).

drugs are approaching treatment is by repairing or correcting improperly transcribed or
mutated genes (Dominski 1993; Friedman 1999; van Deutekom 2001).
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One such antisense ODN, which has been very well studied and useful to caging
research is Alicaforsen (ISIS 2302), which is being developed by the ISIS
Pharmaceuticals. This ODN is currently being researched for its possible medicinal
uses against Crohn’s Disease and Ulcerative Colitis (Gewirtz 2001). Its main target is
the Intracellular Adhesion Molecule-1 (ICAM-1) gene (Bennett 1994). The drug inhibits
the expression of this gene, which is a key factor in many autoimmune and
inflammatory conditions. ICAM-1 can be found in almost all cells of the human body,
and is part of a group of molecules known as Cellular Adhesion Molecules. By
measuring the affects of ISIS 2302 and its ability to be caged, possible control of the
inhibition of the ICAM-1 gene’s expression in living cells can become a reality.
Antisense oligonucleotides although very effective, can repeatedly and
continuously prohibit expression of the target gene, and if not controlled can lead to
possible complications if the proteins being blocked are essential to other processes
within a system. In an effort to develop a control system for this, we have studied the
use of photo-cleavable cage compounds to allow for a method to determine spatial and
temporal aspects of drug functioning. By attaching these cage compounds to the
antisense oligonucleotide, hybridization to its target is blocked. However, once exposed
to near UV-light, the cage compound can be removed and thus fully restoring the
antisense oligonucleotide into a fully functional form. By this method, we allow for
control of the antisense mechanism, while avoiding any loss of potency of the drug.
The importance of targeting through the use of cage compounds is the need to avoid
blockage of gene expression throughout the entire body. By using photo-cleavable cage
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compounds, focused treatments of the antisense can be applied to specific regions of
the body.
Molecular Beacons
The detection of hybridization has been an important tool for understanding the
properties and potential of nucleic acids. One common technique is the use of UVabsorbance to detect the melt profiles or denaturing of nucleic acids. This method
functions on the hyperchromicity characteristic of nucleic acids. Nucleic acids
demonstrate high absorbance of light at approximately 260 nm. Hyperchromicity is the
principle that when double-stranded DNA or RNA denatures, the absorbance at 260 nm
increases, and can be used to detect melting temperatures and hybridization activity.
This technique has been utilized in studies on characterization and thermodynamic
analysis of duplex DNA (Wu 2000), characteristics of modified nucleic acids such as
phosphorothioate ODNs (Stein 1988) and, and DNA hairpin melt studies (Vallone 1999).
This technique has also been employed to study the thermal effects on complexes
formed with heteromorphic duplex DNA (Riccelli 2003). However, this technique is
limited to in-cuvette studies and does not allow real-time study of spatial patterns of
hybridization in cells or tissues.
Molecular beacons are extremely powerful tools that are being used for
demonstrating the photo-control of hybridization activity of caged ODNs. They allow for
differentiation of hybridization activity between native (non-caged), caged, and lightexposed caged ODNs through the use of fluorescence. Fluorescence emissions from
the molecular beacon assays can confirm hybridization activity, and thus can provide
evidence of control of ODN activity through the attachment of photo-cleavable cage
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compounds. Molecular beacons also overcome the limitations of hyperchromicity
absorbance methods by permitting in situ detection of hybridization activity. Spatial
control within cells can be demonstrated once studies are performed to determine the
effects of the caged ODNs in vivo. The beacons may also be helpful in detecting
temporal effects of the caged ODNs by determining the presence of the target mRNAs
and its hybridization activity within the cells.
These probes are a revolutionary tool initially developed in 1996 by Tyagi to help
identify nucleic acid sequences (Tyagi 1996). Molecular beacons are short singlestranded nucleic acids with self-complementing 5’ and 3’ ends. The stems generally are
four to seven bases in length. In between these self-complementing ends is the
sequence complementary to the target of interest. When not in the presence of the
target, the molecular beacon takes a stem and loop form. A fluorophore and quencher
are attached to the 5’ and 3’ ends of the oligonucleotide, respectively. When in close
proximity to the quencher (stem and loop form), the fluorescence emitted is absorbed,

A
B
C
Figure 1.5. Several forms of hybridization probes. These are a basic molecular
beacon (A), a TaqManTM probe (B), and a scorpion beacon (C)
and little to none of it is detected. Hybridized with its target, the fluorophore is
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separated from the quencher, and its fluorescence can be detected as can be seen in
Figure 1.5. The efficacy of the beacons can be altered based on stem and loop
sequence and by the fluorophore and quencher chosen (Tyagi 1998). This includes
numerous applications as discussed below including in PCR, cancer research, clinical
and protein assays.
PCR-based Applications
One of the most common applications for molecular beacons is the monitoring of
PCR reactions in real time. By utilizing these probes in PCR, researchers can monitor
the amplification of nucleic acids during the process (Tyagi 1996; Tyagi 1998). When
using these probes, they are placed into the reaction mixture, and allowed to remain
throughout the amplification process. When at higher temperatures in the cycle,
molecular beacons will dissociate from their hairpin loop form, however will not bind to
the targets, and thus not interfere with amplification process. Once temperatures have
lowered and the amplicon extension has begun, small amounts of the beacon will attach
to the synthesized targets and fluorescence can be detected. Any beacon that is not
attached to the target will remain dark in its closed-stem form at these lower
temperatures. This allows for a sensitive assay to determine the rate of amplification
and quantify rare messages in PCR.
There are several advantages of this molecular beacon assay versus other
techniques. The use of dyes or stains such as SYBR Green and SYBR Gold (Molecular
Probes, Eugene, OR) are limited in that they are non-specific dyes that bind to dsDNA.
They produce signals that may not only represent the target sequence, but also
incorrectly produced segments as well as dimers of the primers. This leads to an
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inability to accurately determine the amount of desired target amplicons in the process.
Several other probes have been designed to achieve a more accurate and efficient
monitoring of the PCR process. Several of these techniques can be seen in Figure 1.5.
TaqManTM probes are simply a probe sequence labeled with a fluorophore on each end.
The first is a donor fluorophore and the other an acceptor fluorophore. Similar to
beacons, the fluorophores are quenched when unhybridized to the target, and utilize
fluorescence resonance energy transfer (FRET) to achieve this. This technique works
by cleavage of the TaqManTM probe when extension begins, and thus breaking up the
probe and releasing the two fluorophores and allowing for fluorescence. The drawback
of this technique is that the probe can only be used once, and then is rendered useless.
Molecular beacons carry on the characteristic of multiple uses versus the single use of a
TaqManTM probe. Another modified version of this probe is the Scorpion primer. Since
the primers are directly linked to the molecular beacons in this type of probe, it allows
for very specific to the amplicon produced since the loop section of the beacon is
complementary to part of the desired amplicon that will be produced (Thelwell 2000;
Taveau 2002).
One example of recent studies of the usage of molecular beacons with RT-PCR
is the use of molecular beacons to detect the Y chromosome in single human
blastomeres in an effort to determine the sex of an embryo (Pierce 2000). This has also
been used as a technique for clone verification (van Schie 2000). Finally there is the
ability of the molecular beacons as tools to identify single nucleotide polymorphisms or
SNPs (Mhlanga 2001), which is currently an intensifying area of research in the clinical
setting due to its high specificity, accessibility, and simplicity. This is also an expanding
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area of study in the identification of mutated genes found within small numbers of cells
in a population, leading to a great range of uses for this technology (Vogelstein 1999).
One of the greatest advantages that accompanies the use of molecular beacons
is multiplexing. The idea of using a multiplex of molecular beacons is quite simple and
quite an advance in comparison to previously used assays. Since molecular beacons
have an extremely high specificity with the ability to distinguish between single
nucleotide mismatches in a target sequence, multiple beacons can be used to
accurately identify several variants of target sequences with as little as a single base
difference. These probes also have great advantage over other fluorescence stains
such as SYBR Green (Molecular Probes, Eugene, OR) in that they can report specific
complementary targets, while SYBR Green and other dyes are non-specific DNA
binding dyes. An initial study by Marras (1999) probed the accuracy of detection of four
molecular beacons, each with different fluorophores, and each differing by as little as
one single nucleotide. This study demonstrated the ability to actively differentiate the
presence of a specific variant of an amplicon present quickly and efficiently (Marras
1999). Many other studies demonstrated the ability of using multiplexed molecular
beacons to quickly and accurately identify specific strains of influenza (Templeton
2003), several types of bacteria (Belanger 2002; Templeton 2003; Varma-Basil 2004),
and numerous viruses (Vet 1999; Klerks 2001; Szemes 2002). The use of these
techniques with quantitative PCR (Q-PCR) can allow researches to quantitatively
determine the levels of specific targets within samples, and thus utilize this in many
numerous ways.
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In the following sections, adaptations of molecular beacons towards immobilized
and other clinical uses will be presented to further underscore this development in the
technology.
Thermodynamic and Kinetic Properties
As probes and diagnostic tools, molecular beacons are well known for their
specificity. The ability for molecular beacons to distinguish between nucleic acids with a
difference of as little as one base pair have been studied since these tools were initially
published by Tyagi and Kramer in 1996. In comparison to linear probes, the hairpin
stem of the molecular beacons allows for much more selectivity when identifying nucleic
acids by reducing the background fluorescence produced by an non-hybridized probe
(Tyagi 1998). Since the hybridization of the molecular beacon to its target can be
manipulated, this allows for the improvement of the ability of the beacons to identify
their targets even in the presence of nucleic acids that may differ by as little as a single
or double base mismatch.
This specificity is affected by several conditions including pH, salt concentration,
and temperature. It has been shown that the negative effect of a single mismatch on the
free energy when two strands of nucleic acids hybridize decreases as the length of the
strands increases. A single base mismatch will have more effect on preventing
hybridization the shorter the strands of nucleic acids (Aboul-ela 1985). This principle
can be seen in molecular beacons, as they are generally short oligonucleotides of about
30 – 40 nucleotides in length. By adjusting the hybridization conditions, one can easily
improve the ability of these probes to identify their targets with a high level of selectivity.
Of the earlier stated conditions, temperature is the most easily and dynamically
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controlled condition to manipulate hybridization reactions. Several studies have
provided insight into the thermodynamics and kinetics of molecular beacons (Bonnet
1999; Tsourkas 2002).
There are three forms in which molecular beacons can exist. These three forms
are the hybridized duplex, self-hybridized in the hairpin structure, and un-hybridized yet
randomly coiled (Bonnet 1999). The likelihood of each state is based on the presence
or absence of the target and the reaction conditions, most notably temperature. By
altering the temperature, the probes will change their form between the three forms
previously mentioned. At temperatures above the melt temperatures of the hybridized
duplex, the probes exist in the un-hybridized, randomly coiled form. As the temperature
cools in the presence of the target, hybridized duplexes of the probe and target will
become more likely along with self-hybridized hairpin forms of the molecular beacons.
Because of the free energy “tax” of a single base mismatch in short oligonucleotides,
such as the 25-mer molecular beacons shown in the Bonnet (1999) studies, these melt
temperatures are much lower. In their study, the single base mismatch was placed in
nine different positions within the target sequence to determine the point at which the
lowest “tax” on free energy would be present (Bonnet 1999). The mismatch with the
lowest strain on the hybridization was the mismatch farthest from the center mismatch,
and had a melt temperature near 31 °C. This differed greatly than that of the
complementary target, which had a melt temperature of approximately 42 °C. As can
be seen in Figure 1.6, once the melt temperature was exceeded, fluorescence rapidly
reduces, thus making the detection of the complementary target even more specific.
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Figure 1.6. Temperature profiles of molecular beacon hybridizations with
perfect target, one base mismatch, two base mismatches, and molecular
beacon alone (MB1 alone) along with the beacon phases for temperatures.
Other studies have focused on the effects of thermodynamic and kinetic
conditions on molecular beacon hybridization to their targets (Tsourkas 2002; Tsourkas
2003). These studies display that not only does the length of the sequence being
targeted determine the specificity of the probe, but also the length of the stems, as well
as their composition have great effect on the selectiveness of the probes to identify their
exact targets. Studies showed that beacons dependent on location, number of
mismatches, and lengths of stem altered the specificity of the probe to identify its
complementary target. Probes with a stem length of four nucleotides showed much less
specificity than those of five or six nucleotides. The probes with stems of six
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nucleotides in length also showed an ability to show greater specificity at lower
temperatures. Not only did stem lengths affect the amount of fluorescence detected
when these probes were hybridized with their targets, they also varied in the amount of
time required for the probes to reach their maximum fluorescence. The shorter the
stem, the higher the overall fluorescence and the shorter the amount of time required to
reach that fluorescence level. This trend alone can be important in designing the
probes, based on the response time sought by the user. One final trend noted in these
studies shows that as stem length increased, melting temperature of the hybridization
duplex reduced. The differences, however, begin to narrow as the probe length
increases (Tsourkas 2003).
In 2002, Tsourkas . published a study showing the kinetics of a shared stem
molecular beacon versus a conventional molecular beacon(Tsourkas 2002). The
initiative was to determine whether a more stabilized fluorophore would help to improve
the use of two molecular beacon systems. The shared stem molecular beacons have
one stem (in this case the stem attached to the fluorophore) that participates in both the
formation of the hairpin as well as the probe target hybridization. This forces the
fluorescent dye into a much more constrained position and thus allows for more control,
as opposed to random coiling that is seen with traditional probes. The results of this
study demonstrated that the melting temperature of the shared stem beacon was higher
for both the complementary target and the single mismatch target, thus leading to a
stronger hybridization between target and probe in the case of the shared stem probe
(Tsourkas 2002). These kinetic and thermodynamic characteristics of molecular
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beacons provide insight into the potential of these probes in the field of function-specific
probe design.
Clinical Applications
As we have discussed, there are many possibilities for the use of molecular
beacons as diagnostic tools in many facets of the scientific community. A promising
application for molecular beacons is to detect disease or mutated DNA within an
organism. The use of such technology would allow for more accurate and much more
rapid results when attempting to diagnose a patient. Many studies have been focused
on the use of molecular beacons in the detection and identification of viruses (Lewin
1999; Szuhai 2001; Kostrikis 2002; Jebbink 2003). Several studies have also focused
on the use of these molecular tools for diagnosing and helping with the treatment of
cancer as well (Arnold 1999; Span 2003; Culha 2004).
Many studies have utilized molecular beacons to detect pathogens (Chen 2000;
Fortin 2001; Lanciotti 2001; Belanger 2002). These studies utilize the principles of
amplification of target DNA through PCR and then utilize beacons to identify the
presence or absence of targets. These probes have also been utilized in research for
quantifying viral loads and the replications of viruses through similar studies (Lewin,
Vesanen 1999; Yates 2001; Yang 2002). The high specificity of molecular beacons to
discriminate between bases with as little as single base differences in their sequences
provides researches with a versatile tool. One particular study has been to quantify viral
loads of the Human Immunodeficiency (HIV), Hepatitis C (HCV), and Hepatitis B (HBV)
viruses with the ability to detect viral loads of as low as 50 copies/mL in the case of HIV
and HBV, and 20 IU/mL of the HCV virus (Abravaya 2003). The two most noted
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characteristics that make the molecular beacon a great diagnostic tool are the reduction
in contamination from post-PCR manual handling and short time required to run the
tests.
Use of molecular beacons along with RT-PCR has been used as a tool to
diagnose and discriminate between many bacteria, such as Bordetella pertussis,
Bordetella parapertussis, and Bordetella Holmessi (Templeton 2003). Earlier studies of
the ability of molecular beacons as tools to diagnose infectious diseases demonstrated
this ability with the respiratory infectious agent Mycobacterium tuberculosis (El-Hajj
2001) and sexually transmitted infectious agents Chlamydia Trachomatus (Zhang
2002). This was also demonstrated in a study for the detection of the presence of
several species of Salmonella through the use of RT-PCR and molecular beacons
(Chen 2000). The trend to develop assays as diagnosis for infectious diseases has
since greatly increased as the use of such a tool in clinical settings poses such great
advancement in health care treatment.
The capability of molecular beacons to be used as genetic assays for other
diseases such as Tay-Sachs has also been demonstrated (Rice 2002). This study
utilized the probes to detect the specific alleles for single copy genes found within a
single cell. By lysing these cells and amplifying the nucleic acids properly through PCR,
one molecular beacon was used to detect the presence of either a normal allele, while
the other was used to detect the 4 base-pair insertion mutated allele, which is one of the
more prominent mutations known to account for a high percentage of Tay Sachs
carriers. This study showed a very accurate detection rate of over 99.1% with a run
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time of only three hours, thus showing that the use of molecular beacons greatly
increased the efficiency of detection of the gene mutation (Rice 2002).
Recent studies have also been focused on the use of molecular beacons as a
diagnostic tool for cancer. As a rapid, accurate, and specific diagnostic tool, molecular
beacons serve as a great tool for early detection of mutations in genes that can lead to
cancer. One example of this is the study by Culha . from 2003 in which they have
shown the use of molecular beacons on a miniature biochip for detection of the BRCA1
gene. As one of the genes known for leading to increased susceptibility to breast cancer
if mutated, early detection and identification is an important tool in prevention (Culha
2004). The use of a molecular beacon based RT-PCR assay has also been
demonstrated as a valid tool with a predictive value when studying breast cancer (Span
2003). This use of molecular beacons with RT-PCR has also been significant in
studying the proteins associated with breast cancer and the ability for metastasis with a
tumor by allowing for detection of the presence of the proteins and their amounts within
the breast cancer. This leads to the conclusion that higher amounts of these proteins
within cancer cells can increase likelihood of metastasis (Arnold 1999).
Applications for molecular beacons as tools with regards to cancer however,
have not been limited solely to breast cancer research. Several studies have focused
on lung cancer as well as a variety of other variations. One example here is the use of
molecular beacons to detect the presence of K-ras point mutations in an effort to
determine predisposition for the illness. Using molecular beacons to both detect the
sense and anti-sense strands of the K-ras Exon 1 compared with the commercially
available elucigene K-RAS7 method showed that this type of assay provides an
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accurate and rapid way to screen large numbers of samples in an effort to get early
detection (Clayton 2000). Another technique has shown that by simply using human
hair shafts and single nucleotide polymorphism PCR, researchers can perform analysis
of genotype by using molecular beacons to identify genomic predisposition to diseases
such as cancer (Chang 2002). This technology provides an opportunity for quick and
non-invasive screening of individuals for genetic mutations that may lead to a greater
likelihood of developing a disease, and thus can be treated to attempt to prevent the
onset of those illnesses.
Project Aims
The overall purpose of this project is to apply the use of photo-cleavable cage
compounds to reversibly control the hybridization activity of DNA oligonucleotides. This
method would provide the basis for spatial and temporal control of the activity of such
specialized ODNs as antisense ODNs, providing a path for overcoming a drawback of
the antisense strategy by allowing for targeting of the ODNs to specific tissues within a
system. The use of cage compounds to afford a light induced control of the ODNs
hybridization activity may provide a simple method for improved drug delivery and more
focused and powerful treatments. Another aim of this project is the development of in
vitro assays in order to help provide evidence of the reversible caging effect. This is
specifically focused on the development of molecular beacon assays based on this
tool’s high level of sensitivity. Molecular beacons provide a window for potent screening
of the temporal control achieved by caging of ODNs with photo-cleavable cage
compounds such as DMNPE and its plausible use with targeted antisense therapies.
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Chapter 2
Control of DNA Hybridization with Photo-cleavable Adducts
Introduction
The hybridization of nucleic acids with their complementary strands is a ratelimiting step in many biological processes and bioassays including fluorescence in situ
hybridization (FISH), microarrays, polymerase chain reaction (PCR), DNA-based
biosensors, molecular computing, RNAi and nanomachines. Strategies to enhance,
limit, or trigger these biological processes often target the hybridization event. It is well
known that the extent of DNA hybridization is significantly dependent on temperature
and ionic environment, and changes in these have therefore been used to control
hybridization. Examples of temperature control are hot-start methods commonly used in
PCR. Ionic environmental control of hybridization has been demonstrated through
environmental modulation of salts or metal ions (Barnes 2002). Recent work
accomplished spatial and temporal control through inductive coupling of
oligonucleotides to metal nanocrystals that provide local heating when exposed to an
external radio frequency field in order to have a broader ability to manipulate biological
functions (Hamad-Schifferli 2002). Here we describe another strategy to control
hybridization of nucleic acids with other forms of energy that enable precise regulation
at the onset. Light was used to activate oligodeoxynucleotides (ODNs) that were
previously inactivated with 1-(4,5-dimethoxy-2-nitrophenyl)diazoethane (DMNPE), a
photocleavable “cage” compound that has been shown to control bioactivity of DNA
plasmids (Monroe 1999).
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Caged compounds have a covalently attached group that can be photocleaved
when exposed to specific wavelengths of light. The “caged” term describes the
blockade of biological activity rather than a chemical structure(McCray 1989; Pelliccioli
2002). Some studies that have shown control with caged compounds are seen within
cellular studies, which include transport of proteins, effects on biological membranes, as
well as muscle fibers (Patton 1991; Ramesh 1993; Ishihara 1997; Lee 1997). Caged
compounds have been used to study the time course of fast cellular processes induced
by a millisecond step increase in the intracellular concentration of a bioactive compound
of interest achieved by a pulse of light exposure. In many of these applications, the
advantages of using photoprotection over conventional methods for substrate release
are that the caged effectors can be dispersed throughout the biological target without
eliciting the species normal bioactivity, the concentration and spatial distribution can be
controlled, and finally, the temporal release can be varied from seconds to nanoseconds
(Givens 1998).
Photoactivatable compounds have been used modulate many aspects of DNA
chemistry and biology. O-nitrobenzyl cage compounds were originally used as a
protecting group in organic synthesis (Pillai 1980). Caged compounds have now been
adapted and used in the caging of nucleotide analogs (Walker 1988), in the synthesis of
bio-chip oligonucleotides (McGall 1996), in studies of the kinetics of DNA repair
(Meldrum 1990; Meldrum 1998; Ordoukhanian 2000), and as protecting groups during
DNA synthesis (Alvarez 1999). Cage groups have also been shown to control an
oligonucleotide hairpin configuration and indirectly hybridization (Ordoukhanian 1995).
The use of cage compounds has also been seen in the repair of DNA that has a single
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strand break at a specific site (Zhang 2001). Inclusion of caged adenosine within
synthesized RNA oligonucleotides enables temporal control of ribozyme and
spliceosome activities (Chaulk 1998; Chaulk 2001).
We have also shown that direct caging of plasmid DNA with DMNPE can block
transcription, allowing for the targeted expression of transgenes in vitro and in vivo
through direct light exposure (Monroe 1999). In addition to controlling the kinetics of a
particular molecular target, caging affords the ability to restrict re-activation to a
localized tissue of interest, as demonstrated by the targeting of transgene expression by
caging hormone inducers or nuclear receptor agonists (Cruz 2000; Lin 2002; Link
2004). More recently, caged mRNA was microinjected in zebrafish embryos to induce
expression of certain genes and study the effect of their expression on developmental
patterns (Ando 2001; Ando 2003). In this report, we explore the application of
photoactivatable cage compounds to reversibly block hybridization of DNA
oligonucleotides.
Materials and Methods
ODN Caging with DMNPE
Unless otherwise specified, reagents were purchased from Sigma-Aldrich (St.
Louis, MO). 5 mg of 1-(4,5-dimethoxy)-2-nitroacetophenone hydrazone (Molecular
Probes, Eugene, OR) and 50 mg of manganese (IV) oxide were gently agitated in 1 mL
of N,N-dimethylformamide (DMF) at 25 °C for 20 min. Manganese oxide was removed
from the 1-(4,5-dimethoxy-2-nitrophenyl) diazoethane (DMNPE) by filtering the solution
through 100 mg of CeliteTM supported by glass wool in a 1 cc tuberculin syringe barrel.
100 µl of the filtrate was agitated with 100 µg of the ODN (2µg/µL) in 200 µl of 10mM
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Bis-Tris (pH 5.5) for 1 hour at 4 °C. Another 60 µl of the active 1-(4,5-dimethoxy-2nitrophenyl)-diazoethane (filtrate) was then added and the solution was agitated for 24
hours at 4 °C.
A second set of caging reactions was run in triplicate using phosphorothioate
ODNs (PS-ODNs). This reaction followed the same procedure as stated above,
however only the initial 100 µl of active DMNPE cage compound was added prior to
overnight agitation. Samples were filtered and then characterized in the same format as
the initial set.
To remove excess unattached cage compound, caged ODNs were purified using
Microcon YM-3 (3000 MW cut-off) centrifugal filters (Millipore, Bilerica, MA). Caged
ODNs were spun at 12x103 G for 100 minutes, and then resuspended in 33% DMF,
stored at 4 °C, and protected from light by wrapping samples in aluminum foil.
Spectral Scanning Protocol and DMNPE Extinction Coefficient Determination
Absorption spectrophotometry of caged species was used to estimate the degree
of caging. Native (non-caged) 20-mer ODN (GCCCAAGCTGGCATCCGTCA,
purchased from Integrated DNA Technologies, Coralville, IA) and DMNPE-caged ODN
were dissolved in 33% DMF in separate cuvettes (DMNPE-caged ODN: 50 µg/ml;
native ODN: 50 µg/ml) and scanned for absorbance from 230 to 500 nm (Thermo
Spectronic Genesys 6, Waltham, MA). Spectral scans of caged-flashed ODNs (caged
ODNS exposed to light) were also made similarly to the above stated methods. To
determine the spectral changes following photoactivation, some of the caged-flashed
ODN products were filtered through the Microcon YM-3 filters following light exposure to
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remove the released 1-(4,5-dimethoxy-2-nitrosophenyl)-ethanone, and then scanned as
described. These samples are referred to as caged-flashed-filtered ODNs.
To approximate the extinction coefficient of DMNPE adducted ODNs,
absorbance peaks at 260 and 355 nm of known concentrations of dilutions of DMNPEcaged ATP in 33% DMF were scanned as above. Moles of DMNPE present were
calculated and the amount of 260 nm absorbance attributed to the DMNPE cage
molecules in the spectra of caged ODNs was determined. These values were then
used with Beer’s Law to calculate ODN concentration and caging efficiency using the
following:
Equations 1 & 2:
• A260 nm = [(ε260 nm, DNA)(CDNA)(L)] + [(ε260 nm, DMNPE)(CDMNPE)(L)]

(1)

• A355 nm = [(ε355 nm, DMNPE)(CDMNPE)(L)]
-C
= Concentration (M)
-1
-1
-ε
= Extinction coefficient (M .cm )
-L
= Path length (cm)

(2)

Equation 3:
• Phosphate Caging Efficiency (Cageeff = percent of phosphates caged)
• Cageeff

= [(CDMNPE ÷ CDNA) ÷ (# of Bases in ODN)] * 100

(3)

Photoactivation and Gel Electrophoresis of Caged ODNs
ODN (250 ng) was run in a 15% polyacrylamide non-denaturing gel in tris-borate
(TBE) buffer (100 mM tris-borate, 2 mM EDTA, pH 8.5) at 70 V for 80 minutes. Cagedflashed samples were prepared by taking aliquots from the 50µg/ml caged-ODN
samples and exposing 365 nm light (dose equivalent to 5.6 mJ/cm2) for 20 minutes prior
to electrophoresis. The light source has a peak output at 365 nm and a fluence rate of
4.68 mW/cm2 at 10 cm (UVP Blak Ray, San Gabriel, CA; Model B 100 AP).
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Spectrographic characterization of this lamp confirmed that the emission spectrum is
365 nm ± 8 nm (USB2000 Fiber Optic Spectrometer, Ocean Optics, Inc., Dunedin, FL).
Gels were stained after electrophoresis with 1X SYBR-Gold nucleic acid gel stain
(Molecular Probes, Eugene, OR) in TBE buffer for 30 minutes. A polyacrylimide nondenaturing gel was also run identically in order to characterize the resulting samples of
caged and caged-flashed phosphorothioate ODNs.
Hybridization of ODNs to Complementary Molecular Beacons
In order to determine the role that DMNPE adduction plays in the disruption of
hybridization of the ODN to complementary DNA or RNA, a hybridization assay using
molecular beacons was developed. Molecular beacons are fluorogenic probes that
signal hybridization with a complementary nucleic acid target (Tyagi 1996). These DNA
oligonucleotides contain a 5’ fluorophore, a 3’ quenching group, and 4-6 complementary
bases on the 3’ and 5’ “stem” ends, which cause the beacon to form a hairpin structure.
Unless the inner “loop” region hybridizes to a complementary nucleic acid, the
fluorescence of the beacon in its hairpin configuration is quenched (Figure 2.1). When
hybridized with a complementary ODN, the hairpin structure linearizes, distancing the
fluorophore from the quencher generating fluorescence (Bonnet 1999).
A molecular beacon (MB1) was designed to hybridize with the specified ODN
used in this experiment (Monroe 2003). The sequence of MB1 was designed with the
aid of mfold, an RNA/DNA folding analysis program (Zuker 2000) and synthesized by
Biosearch Technologies (Novato, CA). The sequence of molecular beacon 1 (MB1) is
5’-FAM-gtgcgTGACGGATGCCAGCTTGGGCcgcac-BHQ1-3’, where capital letters
indicate bases complementary to the caged and native ODN, and lowercase letters
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indicate bases forming the stem region of the beacon. The quenching group in this
beacon is BlackHoleQuencher-1 (BHQ1) and the fluorescent label is [(3',6'-
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Figure 2.1. Hybridization assay of caged probe and complementary molecular
beacon. Non-hybridized molecular beacon assumes the stem-loop
configuration (A) and does not show fluorescence. When hybridized to a
complementary nucleic acid target, the beacon fluoresces (B). Caged
oligonucleotide does not hybridize with molecular beacon (C) until
photoactivated with 365nm light (D). Inset shows theoretical location of
adduction of DMNPE cage molecule at phosphate backbone of the ODN.
dipivaloylfluoresceinyl)-6-carboxamidohexyl]-1-O-(2-cyanoethyl)-(N,N-diisopropyl)phosphoramidite (FAM).
Hybridization of caged and native ODNs with molecular beacon was performed
as follows: 630 ng of native (non-caged), caged, or caged-flashed ODN were mixed with
300 ng of complementary molecular beacon (3.6:1 ODN:Beacon molar ratio) in 100ul
solutions of 100 mM NaCl, 1mM EDTA, pH 7.5. The mixtures were denatured at 90°C
for 5 min and allowed to slowly cool to 25°C over 60 min.
A similar hybridization experiment was also run in order to determine the effects
of caging on the phosphorothioate ODNs. Some changes were noted as only a 1x ratio
as run in order to determine the effects. Samples were otherwise prepared identically to

30

the procedure described above.
Fluorescence Measurements of Molecular Beacons
Fluorescence of hybridization solutions was used to quantify the hybridization of
molecular beacons with ODNs. Each hybridization mixtures (100 µL) was excited at
492nm and emitted fluorescence quantified at 515nm in triplicate with a LS55B
Luminescence Spectrophotometer (Perkin Elmer, Boston, MA).
A functional quantum yield (Φ) was calculated, based on the increases in
fluorescence from the molecular beacon to signal conversion of caged ODNs, based on
Equation 4:

Φ=

1
I ε t90%

(4)

where I is the irradiation intensity in moles of photons cm-2 s-1, ε is the decadic
extinction coefficient of DMNPE in cm2 per mole of substrate, and t90% is the irradiation
time in seconds for 90% conversion (Adams 1988). A value of 4795 M-1cm2 was used
for the 355 nm molar extinction coefficient for DMNPE that was calculated as described
in “spectral scanning protocol”.
Electrophoresis of Caged ODNs and Molecular Beacons
Standard gel electrophoresis was used to confirm hybridization of caged ODNs
with complementary molecular beacons. 210 ng of the ODN-molecular beacon
hybridization mixture was run at 70V in 15% non-denaturing polyacrylamide in TE buffer
(4 mM tris-borate, 0.1 mM EDTA, pH 8.5) for 90 min. Gels were stained in 1x TBE
buffer for 30 minutes as previously described in the non-denaturing gel electrophoresis
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assay with the nucleic acid stain of Sybr Gold. Samples were then visualized under UV
light.
Results
Absorbance Spectrophotometry
Figure 2.2 shows
1.4

the absorbance spectra
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Figure 2.2. Spectral scans of DMNPE-caged, cagedFlashed, caged-flashed-filtered, and native PS-ODN. All
three samples were dissolved in 33% DMF in separate
cuvettes and scanned for absorbance from 230 to 500 nm.

absorbance peak at 355 nm, consistent with the attachment of the DMNPE cage
compound (Walker 1988). Based on the extinction coefficient of attached DMNPE, an
average number of DMNPE caging groups per ODN was calculated as described
previously, but here we also account for the 260nm absorbance of DMNPE due to
higher adduction rates of DMNPE to ODNs than required to inactivate DNA plasmids
(Monroe 1999). Absorbance at 355 nm indicates that caged ODN has approximately
14-16 DMNPE cage groups per 20mer ODN. Once flashed, a shift can be noted in the
355 nm peak that broadens towards longer wavelengths. The absorbance of the

32

released cage group prevents estimation of photoactivation by spectrophotometry, so
some samples were filtered to remove the released cage and then scanned again. The
caged-flashed-filtered ODN product results in an even lower absorbance with a similar
trend in the range of 350 to 370 nm. The caged-flashed-filtered ODN has approximately
2-4 DMNPE cage groups per ODN.
Non-denaturing Gel Electrophoresis
Electrophoresis of caged ODNs shows characteristic changes in mobility
30 20

10

(Base Pairs)
10 Base pair ruler

corresponding to the addition and
removal of the DMNPE caging groups
(Figure 2.3). The DMNPE-caged

Native ODN
oligonucleotides have reduced mobility
LightInduced
Shift

Caged ODN

compared to that of native

Caged-Flashed
ODN

oligonucleotides. A light-induced
change is seen between the caged

Figure 2.3. Non-denaturing gel
electrophoresis of DMNPE-caged and native
phosphodiester ODNs. Caged-flashed
samples were exposed to 5.6 mJ/cm2 of 365
nm light immediately prior to electrophoresis.

and caged-flashed samples, with the
caged-flashed band having mobility
more comparable to the native ODN

subjected to caging conditions and processes of the caging reaction, but without the
addition of DMNPE. The intensity of the band corresponding to the caged ODN was
also less than the caged-light-exposed and native ODNs, suggesting an alteration of the
ODN that interferes with its staining.
In Figure 2.4, the native phosphorothioate ODN does however electrophorese
much closer to the 20 base pair marker in the molecular ruler, thus showing a reduced
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mobility. Also, very little staining is seen in the caged phosphorothioate ODN compared
to native phosphorothioate ODN, corresponding to a greater amount of cage compound
attached to the ODNs. Restoration of the ODNs to mobility and staining characteristics
closer resembling that of the native ODN can be seen with the light induced shift
between the caged and caged-flashed samples.

Caged-Flashed
ODN

Light
induced
Shift

Caged ODN
Native ODN
10 base pair ruler

30 20

10

(Base Pairs)

Figure 2.4. Non-denaturing gel
electrophoresis of DMNPE-caged and native
phosphorothioate PS-ODNs.
Fluorescence Measurements of Hybridization Products
Fluorescence emissions from a complementary molecular beacon indicate
differing amounts of hybridization for caged and native ODNs (Figure 2.5). The relative
fluorescence of molecular beacon in solution alone was 34.6 ± 9.4 (mean ± SD, n=3)
relative fluorescence units (RFUs) and 414 ± 34 RFUs when native compliment was
added. Fluorescent emission of the hybridization mixture of caged ODN and molecular
beacon is 89.2 ± 8.3 RFUs, which is 14.4% of the relative fluorescence of the native
probe hybridization mixture when background signal of molecular beacon alone in
solution is removed, indicating a low level of hybridization. However, the caged-light-
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exposed sample shows an increase in fluorescence to 336 ± 8.0 RFUs, which is 79.5%
of the native solution, indicating an increase in hybridization of the photoactivated
ODNs. Significant difference from beacon alone is denoted by the cross symbol, while
asterisks denote significant difference from both caged ODN and beacon alone (n = 3,
p<0.05, Bonferroni’s t-test).
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Flashed ODN

Figure 2.5. Relative fluorescence intensities from solutions of molecular beacon
hybridized with phosphodiester native, caged or caged-light-exposed ODNs.
630 ng of native, caged, or caged-light-exposed ODNs were mixed with 300ng
of molecular beacon (3.6:1 target:beacon molar ratio) and tested for
hybridization in a fluorescence spectrofluorimeter. Significant difference from
beacon alone is denoted by cross symbol, while asterisks denote significant
difference from caged ODN also (n = 3, p<0.05, Bonferroni’s t-test).
In the case of the phosphorothioate caged ODNs in comparison, restriction of
hybridization by the cage compound was much greater than that of the phosphodiester
ODNs. As seen in Figure 2.6, the relative fluorescence for the molecular beacon alone
was 53.4 ± 0.9, while the native ODN had a fluorescence of 974 ± 18. The fluorescence
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emission of the caged ODNs in this set of samples was 61.4 ± 0.7, or 0.88% of the
native solution when the background noise is removed as stated above. Once again,
when exposed to UV-light of 365 nm, the activity is restored, although not as greatly as
with the phosphodiester samples. The caged-flashed ODN in this experiment had a
fluorescence of 217 ± 6.7. This is equivalent to a restoration of the ability to hybridize of
the sample to 17.8% from 0.88%, which is over a 20-fold increase of hybridization from
caged to caged-flashed ODNs.
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Native ODN
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Figure 2.6. Relative fluorescence intensities from solutions of molecular beacon
hybridized with phosphorothioate native, caged or caged-light-exposed ODNs. 630 ng of
native, caged, or caged-light-exposed ODNs were mixed with 300ng of molecular beacon
(3.6:1 target:beacon molar ratio) and tested for hybridization in a fluorescence
spectrofluorimeter. Significant difference from beacon alone is denoted by the cross
symbol, while asterisks denote significant difference from caged ODN and beacon alone
(n = 3, p<0.05, Bonferroni’s t-test).
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Non-denaturing Gel Electrophoresis of Hybridization Products
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Figure 2.7. Inverse image of non-denaturing gel of hybridization products from
caged and caged-flashed samples of hybridized oligonucleotides. Changes in
hybridization of native, caged and caged-flashed mixtures of probe ODNs and
molecular beacon were analyzed for changes in intensity of the band
corresponding to the duplex conformation.
To confirm the results from the solution measurements of molecular beacon
hybridization, non-denaturing polyacrylamide electrophoresis was used to show gel
mobility shifts upon hybridization with caged and caged-light-exposed ODNs. Note the
changes in the hybridized duplex and non-hybridized ODN band intensities between
caged and caged-flashed samples (Figure 2.7, lanes 2 & 3). Caged ODN does not
completely hybridize with its complementary sequence on the molecular beacon.
However the sample that was exposed to light shows more ODN in the duplex form,
resembling that of the non-caged native probe hybridization (shown for comparison in
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Lane 4). The non-hybridized molecular beacon does not stain well when run in a gel at
these concentrations, possibly due to the beacon’s quenching of the nucleic acid stain
used (lane 5).
Light dose-response of caged ODNs and Molecular Beacons
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Figure 2.8. Effect of cumulative light exposure time on solution
fluorescence of caged ODN-molecular beacon hybridization
mixtures, with times of 1, 2, 5, 10, and 20 minutes. Significant
difference from caged ODN (0 minutes) denoted by asterisks (n = 3,
p<0.05, Bonferroni’s t-test).
To determine the proper dose of light exposure required for photoactivation of
caged ODNs, hybridization mixtures were exposed to increasing durations of light
before denaturating and fluorescence measurement (Figure 2.8). Fluorescence
emission increased with increasing light exposure, from 230 RFU with no light
exposure, to values of 302, 325, 344, 372 and 380 RFU with light exposures of 1, 2, 5,
10, and 20 minutes, respectively. Significant difference from caged ODN (0 minutes)
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denoted by asterisks (n = 3, p<0.05, Bonferroni’s t-test). All of the samples showed a
significant difference from the control sample. The experimental data retrieved from this
section was utilized to determine the functional quantum yield for the caging of ODNs
with DMNPE (see Equation 4).
Discussion
Our data suggests that the adduction of photocleavable cage compounds to DNA
oligonucleotides (ODNs) can reversibly block hybridization. This strategy relies on the
covalent attachment of a cage compound, which disrupts DNA bioactivity until
photocleavage restores DNA to its native and bioactive form. We have partially blocked
ODN bioactivity with the cage compound DMNPE, the same compound that has been
shown to reversibly control transcriptional activity of plasmid DNA (Monroe 1999).
Absorbance data and gel shifts indicate that DMNPE adducts to ODNs and is
photocleaved with 365 nm light. Spectral scans show characteristic absorbance at 355
nm (Figure 2.2).

Similar to DMNPE-caged plasmid DNA and DMNPE-caged ATP,

absorption at this wavelength is consistent with the presence of DMNPE caging groups,
as native DNA does not absorb in this region. Calculations based on the extinction
coefficient of attached DMNPE indicate that there is an average of 14 to 16 cage
molecules present per 20-mer ODN. The spectral scans in Figure 2.2 also indicate that
photo-cleavage of the caged ODNs was achieved. The filtration of the flashed products
(caged-flashed-filtered) confirms this as the absorbance at the 355 to 390 nm range
decreases once the sample was filtered. By filtering the caged-flashed product,
released cage could be removed, and thus a more effective characterization of the
flashed product was possible. In gel electrophoresis, caged ODNs have lower
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electrophoretic mobility than native (non-caged) ODNs (Figures 2.3 & 2.4).

This

observation is consistent with the attachment of the non-polar DMNPE cage groups that
retard ODN mobility by neutralizing otherwise negative charges on the phosphodiester
backbone or base structures. It was originally hypothesized that the DMNPE attaches
to the phosphate backbone of DNA, similar to its demonstrated attachment to
phosphates of nucleotides (Walker 1988).

While structural studies of the DMNPE-

caged ODNs have not been completed to date, alterations in staining intensity between
caged and native ODNs (lanes 2 and 3) suggest that attachment of the DMNPE may
also block some reported base-associated labeling of the SYBR-Gold nucleic acid stain
used to visualize these ODNs in gels (Tuma 1999). Even if the majority of DMNPE
adduction occurs at the phosphate backbone of the ODN, this conformation may still
disrupt hybridization, as shown with other phosphate modifications (Jeong 1999).
Two assays utilizing molecular beacons demonstrate that caging ODNs modified
their hybridization activity. The switch-like fluorescence properties of the molecular
beacon allow it to act as a direct measure of hybridization, so that solutions of
hybridized ODN and beacon can be assayed for hybridization directly in a
spectrofluorimeter. Fluorescence emission of a hybridization mixture of caged ODNs
and complementary beacon is much lower than that of the native hybridization mixture
(Figures 2.5 & 2.6). When exposed to 5.6 J/cm2 of 365 nm light prior to hybridization,
fluorescence emission increases, indicating a restoration of hybridization activity. When
the background of native probe alone is subtracted, the level of activity between the
caged and caged-light-exposed ODN-beacon hybridization increases from 15% to 79%
of the native ODN’s activity. This was also the case in the hybridizations run with the
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phosphorothioate caged ODNs. However in this case, a much higher suppression of
the ODN was achieved at 0.88% and restored to 17.8%, or over a 20-fold restoration.
To corroborate the results found in solution, molecular beacons were also used in a
non-denaturing PAGE assay, to show shifts in gel bands upon hybridization (Figure
2.7). Decreased intensity of the band representing the duplex hybridization of 20mer
ODN and 30-mer molecular beacon shows that caged ODN does not completely
hybridize with a complementary beacon. When exposed to 365 nm light prior to
hybridization and electrophoresis, cage groups are photocleaved from the ODN allowing
it to hybridize. The caged-light-exposed sample showed a stronger band in the duplex
conformation resembling that of the non-caged native probe hybridization. The
presence of a stronger band of the 20-mer non-hybridized ODN in the caged sample
that disappears in the flashed sample also confirms the alteration of hybridization
activity seen in solution.
Restoration of hybridization of caged ODNs is a light-dependent process as seen
in the 365 nm light dose response of hybridization activity in Figure 2.8. An exponential
relationship is seen between the amount of fluorescence from a molecular beacon and
increasing light exposure, with a dose1/2 of 0.288 J/cm2. It is difficult to compare this
dose of light with other photolysis studies because most caged compounds are directly
synthesized with only one cage moiety per effector molecule. However, the doses for
functional restoration of DMNPE-caged ODNs do appear to be within the range of other
published values of photolysis for similar cage compounds and light delivery systems
(Rossi 1997; Rinnova 2000). The caging group used here, DMNPE, in general has
relatively low quantum yields when compared to other caged groups. For instance, the
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reported Qp for DMNPE-caged ATP is 0.07, much lower than the 0.63 Qp of NPE-caged
ATP (Walker 1988; Wooton 1989). An attempt to estimate the functional quantum yield
of DMNPE-caged ODNs was made based on the increase in functional activity with light
exposure in the beacon assay in Figure 2.8. The measured increase in hybridization
was used to determine complete conversion rather than the traditional method of
quantum yield determination from absorption increases. The fact that each caged ODN
has multiple DMNPE adducts precludes the simple use of an absorption increase
because restoration of hybridization may not correlate with the photoconversion of less
than all the attached cages. Our calculations indicate that DMNPE-caged ODNs have a
functional quantum yield of at least 0.09. This number assumes a 100% response from
the molecular beacon to indicate hybridization of a photoreleased ODN, which may not
be the case. Lower efficiencies of the molecular beacon system in detecting
hybridization of a photoactivated ODN would impart increases to the resulting quantum
yield.
Modifications of the strategy could lead to improvements in blockade and
subsequent restoration of hybridization of ODNs. Since our initial report of caging
plasmid DNA with DMNPE, other promising cage groups have been identified. For
example, brominated 7-hydroxycoumarin-4-ylmethyls (BHC), a modification of Tsien’s
bromocoumarin cage, has recently been used to randomly cage mRNA, allowing it to be
activated at selected sites for translation in zebrafish embryo’s, facilitating the
elucidation of several genes involved in development (Ando 2001). BHC reportedly has
better quantum efficiencies than DMNPE, which would require less light for complete
photocleavage after delivery to cells (Furuta 1999). In addition to a lower light dose, the
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architecture of light exposure to tissue could be engineered to minimize cellular-induced
responses, while maximizing total dose of light delivered to the caged ODNs. Twophoton excitation could be an alternative technique for photoactivation of caged ODNs
(Piston 1999).

Longer wavelengths utilized in the two-photon uncaging have lower

energy than the 365 nm light, causing less photodamage to cells and tissues (Denk
1995). The longer wavelengths also have deeper tissue penetration and would allow
targeting at greater depths. This technique, combined with newer cage molecules
having biologically useful 2-photon cross-sections, could minimize cellular damage
while increasing targeting precision (Furuta 2004).
A significant improvement in this strategy would be to cage a single nucleotide
and incorporate it into ODN synthesis. This approach offers the advantage of
controlling precisely the number and attachment site of cage groups to each ODN.

It

is also possible that different attachment sites of the caging moiety on the ODN will
have different rates of photorelease. If the caging sites which give the highest efficiency
of photorelease could be identified, caging conditions or synthetic strategies to
incorporate the cage in a site specific manner can be developed to target those
positions which are most readily released upon irradiation.
In summary, our data indicate that light-activated hybridization can be achieved
with the use of photocleavable cage compounds. Spectrophotometric, gel-shift, and
molecular beacon fluorescence data indicate that caged compounds can be used to
reversibly alter the hybridization activity of single stranded DNA. Attachment of DMNPE
to phosphodiester ODNs presents a strategy for the temporal and spatial control of
hybridization. This strategy has application in controlling DNA hybridization activity
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such as primer activity in PCR, FISH, microarrays, molecular computers,
nanomachines, DNA-biosensors and targeting of antisense ODNs to specific locations
in tissues. Extension of this technique to phosphorothioate ODNs and RNAi species
could be applicable in controlling gene silencing and protection of these compounds
from enzymatic degradation.
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Chapter 3
Optimal Solvent Selection and Purification Techniques for DNA
Oligonucleotide Caging
Introduction
The aim of this study is to determine an optimal solvent and purification
technique combination to allow for effective and efficient characterization of DMNPEcaged ODNs. Selection of an appropriate solvent is necessary to allow for a consistent
and potent reaction, while also allowing for proper characterization of the caged
products. Determination of the optimal purification technique is an important step in
providing a valid assessment of the cage compounds abilities to control oligonucleotide
hybridization activity. Presence of excess cage does not allow for proper assessment of
the purification method, and may have negative effects in future in vivo studies.
In an effort to improve efficiency of the caging reaction and characterization of its
products, we chose to look at the effects of different solvents in the caging reaction of
DMNPE with DNA oligonucleotides (ODNs) as previously described in chapter 2.
Proper solvent selection was necessary to promote cage attachment, avoid denaturing
and irreversible alterations of the DNA, provide separation of products from unattached
cage compound, and to facilitate accurate characterization. Study of the effects of
solvents such as N,N-dimethylformamide (DMF) or dimethyl sulfoxide (DMSO) on
nucleic acids has shown denaturing through activity of endonuclease S1 (Wetmur
1968). DMSO has also recently been used for the reaction of cage compounds with
nucleic acids in an effort to develop a photo-control method for hybridization (Monroe
1999; Ando 2001).
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DMNPE has minimal solubility in water (Walker 1988), and thus is problematic
when working with ODNs aqueous solutions. In studies on caging of DNA plasmids,
33% dimethyl sulfoxide was used in mixture with a 10mM Bis-Tris solution, allowing for
solubility levels that were adequate to keep the caged DNA plasmids in solution
(Monroe 1999). However, more heavily caged samples are more likely to precipitate in
an aqueous solution, due to higher amounts of the hydrophobic cage compound. It was
also noted that DMSO would crystallize at 4ºC in the reaction, thus preventing a full
reaction from taking place when used with DNA ODNs. DMF was initially chosen to
replace DMSO, as they share very similar properties and DMF does not crystallize at
4ºC. One drawback of using DMF, however, is the high extinction coefficient of the
solvent at wavelengths of 200 to 260 nm, thus providing possible difficulty in accurately
characterizing the ODNs. Four organic solvents, chosen based on previous use or
compatibility with materials used,
were evaluated to determine the
optimal choice for caging DNA ODNs
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Figure 3.1. Structures of Solvents tested.

Structures of these solvents can be seen in Figure 3.1.
Purification of the caged ODN products upon completion of the chemical reaction
was also studied. The presence of excess cage compound required separation of the
target caged DNA ODNs from the reaction volume. Initially performed chloroform
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extractions and ethanol precipitations by Monroe (1999) with DNA plasmids, this
technique was not efficient at separation of the caged and native DNA ODNs from the
excess cage compound due to the greater degree of DMNPE adduction with the more
heavily caged products portioning into the organic phase. This was most notable with
the phosphorothioate DNA ODNs, which were more reactive with the cage compound
when compared to the phosphodiester DNA ODNs. In order to account for this issue, a
study was run to determine an efficient method for purifying the reaction volumes. The
three methods studied were the use of Slide-a-Lyzer dialysis (Pierce Biotechnology,
Rockford, IL), Sephadex G-25 Oligo Quick Spin columns (Roche, Basel, Switzerland)
and Microcon YM-3 molecular weight cut-off filters (Millipore, Bilerica, MA). Upon
completion of this study, optimal caging reactions could be performed and
characterized, thus allowing for an efficient investigation of the ability to control DNA
ODN hybridization with DMNPE.
Materials and Methods
DMNPE Cage Compound Solubility
DMF, isopropanol, methanol, and acetonitrile were tested to determine the
solubility of DNA oligonucleotides (ISIS 2302) and DMNPE cage compound. In order to
determine the solubility of the cage compound in the organic solvents, a 5 mg sample of
1-(4,5-dimethoxy)-2-nitroacetophenone hydrazone (DMNPE hydrazone) was dissolved
in 1 mL of DMF, and aliqouted into 50 µL volumes that were then dried down to 5 µL
and resuspended in 300 µL of MeCN, DMF, IPA, or MeOH. Spectrophometric scans of
these samples were then performed from 200 nm to 500 nm (baselined in their
respective solvent) in order to determine solubility.
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To determine whether activated DMNPE has differing solubility in these solvents,
the DMNPE hydrazone solution used above was activated using 35 mg of MnO2,
followed by covering the samples in aluminum foil. The samples were then vortexed for
15 seconds followed by agitation at 4 ºC for 20 minutes. The samples were then placed
in a microcentrifuge for 30 seconds and filtered through 100 mg of Celite supported by
glass wool to remove the MnO2. After filtration, a second set of aliquots was made as
described in the initial DMNPE solubility study from the activated solution. These
samples were then dried and resuspended to a volume of 300 µL in one of the solvents
and scanned in the spectrophotometer as previously described.
DNA Oligonucleotides in Various Solvents
DNA ODNs were dissolved in either pure solvents or 33%, 50%, 66% mixtures of
each with HPLC grade water in order to determine solubility. Previously made solutions
of both phosphorothioate and phosphodiester 20-mer ODN (ISIS 2302) were initially
diluted in water to 50 µL at a concentration of 0.05 µg/uL and dried down in a vacufuge
at 30 ºC to a final volume of 5 µL. Samples were then resuspended, one of each type
of ODN in the four aforementioned pure solvents up to a volume of 300 µL and scanned
in a spectrophotometer as previously described.
DNA Oligonucleotides in Mixed Solvents
Based on the results of the initial experiment, further samples were prepared with
acetonitrile or methanol in mixture with water as solvents. 100 µL samples of the DNA
ODNs (0.05 µg/uL) were each brought up to 300 µL in final volume by adding one of the
solvents and water to make solutions of 33%, 50%, and 66% of each organic solvent in
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water. These samples were then scanned in the spectrophotometer as in the previous
experiment to determine sample solubility.
Purification Technique Evaluation
To determine the most efficient method of purification, two caging reactions (300
µg of DNA ODN, 300 µL of activated DMNPE) were run following the protocol located in
Appendix B, one with phosphodiester DNA ODNs and the other with phosphorothioate
DNA ODNs. Three 300 µL aliquots of each completed reaction were then prepared. An
additional standard reaction was also run with phosphodiester DNA ODNs for
comparing a second protocol used with the Microcon YM-3 filter with additional washes
to help improve removal of the unattached DMNPE. Samples were then scanned in a
spectrophotometer and characterized quantitatively. Working stocks were prepared for
each reaction at a concentration of 50 µg/µL, and then analyzed in molecular beacon
hybridization and gel electrophoresis assays following the same methods found in
chapter 2. Samples were compared and analyzed to determine which purification
technique was the most promising in several categories, such as volume, duration,
ODN recovery, and cost.
Variable Solvent Caging Reaction
Three caging reactions were performed as stated in chapter 2 with various
solvents in place of DMF. This reaction was run in DMF, MeOH, and DMSO. Samples
of DMNPE hydrazone were activated in each of the solvents, and then the reaction was
performed accordingly. The cage sample was then reacted with both phosphodiester
and phosphorothioate ODNs. Samples were only reacted with 100 µL of active
DMNPE. In all steps of the reaction and subsequent purification, DMF was replaced
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with the solvent of choice. Upon completion of the reaction and purification,
spectrophometric scans were taken and samples were assessed in molecular beacon
hybridization identical to protocol in chapter 2.
Results
DNA Solubility in Solvents
Figure 3.2 shows the
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µg/µL. In Figure 3.3, the same experiment showed the absorbance spectra of
phosphorothioate DNA ODNs (PS ODNs). In this case, a confirmed peak at 260 nm for
the DMF sample was observed, while a visible peak was noted for the methanol
sample. This however was not the case in the acetonitrile and isopropanol samples.
The next step in the study looked at the solubility of the two types of DNA ODNs
in solvents of a mixed nature. The two solvents studied here were acetonitrile and
methanol. DMF was not tested as it is shown that the ODN is soluble in the solvent in
Figure 3.3. In Figure 3.4, samples of PD ODNs were in mixtures of methanol, and all
remained similar to the spectrum in water. The PD ODNs behaved similarly in
acetonitrile, however these samples were slightly more variable in their absorbance
near 260 nm as can be seen in Table 3.1. There was also a slight shift in the peak,
however this was very minimal and within one to two nm. The PD-ODNs in DMF also
behaved similarly.
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Figure 3.4. Spectrophotometer Scans of Phosphodiester
DNA Oligonucleotide Solubility in Methanol Mixtures.
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Looking at Table 3.1, phosphorothioate ODNs followed a similar spectra to that
of the phosphodiester ODNs although there was more variation between the peaks the.
Some unique trends in the phosphorothioate samples were seen with acetonitrile
mixtures. The 33% acetonitrile sample had a higher peak than the 50% sample,
however the 66% sample is higher than both, but all are within the error of the
spectrophotometer. This was the same case for the DMF samples.
Table 3.1. 260 nm absorbance for ODNs in DMF, methanol and acetonitrile mixtures.
Solvent Mixture
Water
33% Methanol
50% Methanol
66% Methanol
33% Acetonitrile
50% Acetonitrile
66% Acetonitrile
33% DMF
50% DMF
66% DMF

Phopsphodiester ODN
260 nm Absorbance
0.98
1.01
1.04
0.96
1.12
1.05
1.03
1.08
1.23
1.07

Phosphorothioate ODN
260 nm Absorbance
1.14
1.28
1.34
1.37
1.31
1.24
1.45
1.11
1.30
1.27
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Figure 3.6. Spectrophotometer scans of active
DMNPE cage compound in organic solvents.

nm wavelength regions.
Spectrophometric Scans of Purification Technique Reactions
The spectrophotometer
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Figure 3.7. Spectrophotometer scans of caged
phosphodiester DNA ODN after various filtration
techniques.
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had the highest 355 nm peak. The Microcon YM-3 filter’s 355 nm absorbance dropped
dramatically when the extra washes were performed, while it also maintained most of its
260 nm peak.
The caged phosphorothioate ODNs behaved slightly different as is shown in
Figure 3.8. Here, the 260 nm peak for the Microcon YM-3 filter was once again the
highest. The 260 nm peak of the G-25 Sephadex filter showed very little PS-ODN
present, and also had a relatively low 355 nm peak. The 355 nm peaks of the other two
filters however varied greatly showing a much lower peak for the Slide-a-Lyzer.
1.2

G-25 Sephadex Filter
Slide-a-Lyzer
Microcon YM-3 Filter

1.0
0.8
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0.6
0.4
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Figure 3.8. Spectrophotometer scans of caged
phosphorothioate DNA oligonucleotide after various
filtration techniques.
Table 3.2. Caging reaction characteristics for various filtration techniques.
ODN Type & Purification
Technique
PD Sephadex
PD Dialysis
PD Amicon
PD Amicon with washes^
PS Sephadex
PS Dialysis
PS Amicon

Perceived Caging
Efficiency
65.38%
77.44%
113.7%
38.11%
85.8%
106.6%
169.3%
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% Yield of ODN
56.0%
22.4%
106.5%
93.4%
22.0%
37.2%
82.0%

ODN yields and perceived caging efficiencies for each purification technique
were calculated from the spectrophotometer scans identically to those performed in the
previous chapter and displayed in Table 3.2. Since aliquots from the same reaction
were used with each technique, the actual caging efficiency remained the same for all.
Variations are entirely based on the presence of unattached DMNPE and the DNA
retained in the purified samples. The total amount of oligonucleotide was out of an
initial 100 µg of DNA oligonucleotide. Caging efficiency was determined by the amount
of cage present and number of possible binding sites available in the solution as
described in chapter 2. Values for caging efficiency greater than 100% indicated an
excess of unattached DMNPE cage compound not filtered from the sample. This could,
however, also have been due to the cage compound binding to sites other than the
predicted sites along the phosphate backbone. Higher caging efficiencies with
phosphorothioate ODNS could possibly be due to a difference in extinction coefficient
when attached to the sulfur atom as well as possible complications with purification
methods. It was noted that as the reaction was visibly more active for phosphorothioate
ODNS with greater N2 gas production and a much quicker color change of the reaction
volume from red to yellow.
Gel Electrophoresis of Purification Technique Reactions
Gel electrophoresis of the caged ODNs showed the normal characteristic
changes in mobility and staining normally attributed to adduction and photo-release of
the DMNPE cage compound for all of the techniques. PD caged samples (Figure 3.9)
all behaved similarly with reduced staining and mobility. Upon exposure to light, the
staining and mobility of all samples were partially restored.
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A-F

Figure 3.9. Non-Denaturing Gel Electrophoresis of
DMNPE-caged and native PD-ODNs
C = caged sample, F = Caged-flashed Sample.
S = G-25 Sephadex filter, D = Slide-A-Lyzer Dialysis,
and A = Microcon YM-3 Filtered samples.
The same trend was seen in the gel electrophoresis results for the PS ODNs
displayed in Figure 3.10. In this gel, the most improved restoration of staining ability
was attained from the samples run through the G-25 Sephadex filter. It should be noted
that very little of the actual DNA was recovered during the G-25 Sephadex purification,
and so required a greater amount of the sample to bring it to the desired concentration.

30 bp
20 bp

10 bp
A-F

A-C

D-F

D-C

S-F
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Native

Ruler

Figure 3.10. Non-Denaturing Gel Electrophoresis of
DMNPE-caged and native PS ODNs.
C = caged sample, while F = Caged-flashed Sample.
S = G-25 Sephadex filter, D = Slide-A-Lyzer Dialysis, and
A = Microcon YM-3 Filtered samples.
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Fluorescence Measurements of Molecular Beacon Hybridization Products
Fluorescence emissions of samples hybridized with the molecular beacon
provide evidence as to the ability of the DMNPE cage compound to control
hybridization. As seen in Figure 3.11, the purified caged PD ODNs for each technique
showed reduction in hybridization with the molecular beacon. A background noise
value of the molecular beacon alone was of 32.4 relative fluorescence units (RFUs),
while the solution containing the native PD ODN and the molecular beacon had a very
high value of 490 RFUs. The caged samples all ranged from a low value of 62.9 to a
high of 69.4 RFUs. Once exposed to UV-light of 365 nm in wavelength, all three
samples recovered some ability to hybridize with the molecular beacon ranging from

Relative Fluorescence Units

values of 220 to 268 RFUs.
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200.0
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32.4
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66.3

258

62.9
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Figure 3.11. Molecular beacon hybridization assay of caged
PD ODN samples.
C = Caged Sample F = Caged-Flashed Sample
S = Sephadex Filtration, D = Dialysis Filtration, and
A = Amicon Filtration
This was not the case in the run containing the phosphorothioate ODNs. As can
be seen in Figure 3.12, restoration of the capacity to hybridize was negligible, however
the cage compounds prevention of hybridization was greater in the case of the PS
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ODNs. Previous experiments as shown in Figure 2.6 of chapter 2 have provided some
evidence that PS ODNs can be successfully caged and then restored with exposure to
light. The difference between the two sets of experiments was the use of follow up

Relative Flourescence Units

washes during the purification process.
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Figure 3.12. Molecular beacon hybridization assay of caged PS
ODN samples.
C = Caged Sample F = Caged-Flashed Sample
S = Sephadex Filtration, D = Dialysis Filtration, and
A = Amicon Filtration
Various Solvent Caging Reactions: Fluorescence Measurements of Molecular
Beacon Hybridizations
Fluorescence emissions from a complementary molecular beacon indicate
differing amounts of hybridization for caged and native PD-ODNs in various solvents
(Figure 3.13). The relative fluorescence of molecular beacon in solution alone was 27.0
± 0.7 (mean ± SD, n=3) relative fluorescence units (RFUs) and 440 ± 15 RFUs when
native compliment was added. Fluorescent emission of the hybridization mixture of
caged ODN (DMF) and molecular beacon is 90.7 ± 5.1 RFUs, which is 15.4% of the
relative fluorescence of the native probe hybridization mixture when background signal
of molecular beacon alone in solution is removed, indicating a low level of hybridization.
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The caged-light-exposed ODN (in DMF) showed an increase in fluorescence to 231 ±
4.2 RFUs, which is 49.4% of the native solution, indicating an increase in hybridization
of the photoactivated ODNs. In the case of ODNs in DMSO, the caged ODN showed a
fluorescence of 77.0 ± 1.1 RFUs or 12.1% the activity of native ODN, while caged-lightexposed ODNs had a fluorescence value of 164 ± 8.1 RFUs or 33.2% of native activity.
The last samples were studied with methanol as a solvent. The caged-ODN in this case
had a relative fluorescence of 365 ± 6.8 RFUs or 81.8% activity of native, where as the
caged-light-exposed ODNs had an increased fluorescence of 397 ± 13.4 RFUs or
89.6%. Significant difference from beacon alone denoted by crosses asterisks, while
asterisks also denote significant difference from caged ODN (n = 3, p<0.05, Bonferroni’s
t-test).
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Figure 3.13. Molecular beacon hybridization assay of caged PDODN samples in various solvents.
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In the case of the phosphorothioate caged ODNs in comparison, restriction of
hybridization by the cage compound was much greater than that of the phosphodiester
ODNs. As seen in Figure 3.14, the relative fluorescence for the molecular beacon alone
was 27.0 ± 0.7, while the native ODN had a fluorescence of 391 ± 9.8. The
fluorescence emission of the caged PS-ODNs in DMF was 31.3 ± 0.5, or 1.18% of the
native solution when the background noise is removed as stated above, while the
caged-light-exposed PS-ODNs had a relative fluorescence of 68.7 ± 3.5 or a value of
11.5% activity. Samples in DMSO faired similarly with a fluorescence of 39.0 ± 2.0
RFUs (3.30% activity) for caged PS-ODNs and 67.4 ± 2.2 RFUs (12.5% activity) for
caged-light-exposed ODNs. Phosphorothioate samples tested in methanol (MeOH)
behaved differently

methanol with a
caged-ODN
fluorescence of
49.5 ± 0.6 RFUs
(6.18% activity) and
a caged-lightexposed ODN
relative
fluorescence value
of 86.8 ± 3.4 RFUs
(16.4% activity).
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Figure 3.14. Molecular beacon hybridization assay of caged
PS-ODN samples in various solvents. Significant difference
from beacon alone denoted by crosses asterisks, while
asterisks denote significant difference from caged ODN and
beacon alone (n = 3, p<0.05, Bonferroni’s t-test). PS-ODN
caged in DMF showed insignificant difference when compared
to beacon alone with the same test.

60

Discussion
Data indicates that solvent choice did have an effect on the efficiency and ability
to characterize the ODN caging reactions. In the chapter 2, we demonstrated that use
of the DMNPE cage compound allowed for temporal control of the ODN’s hybridization
activity. By optimizing the solvents, we were able to ensure the most promising cage
attachment, purification, and performance of light-activated hybridization. The initial
step of this study was to identify the solvent that could replace dimethyl sulfoxide
(DMSO), which was previously used with plasmid DNA caging (Monroe 1999). Due to
its relatively high freezing point, and the preferable reaction of DMNPE with the DNA
ODNs at 4 ºC, DMSO was limiting in the efficiency of the caging reaction.
The initial focus of this study was to determine the solubility of the cage
compound (DMNPE) and ODNs in several solvents. It was also necessary to determine
whether the ODNs and cage compound could be accurately characterized in the
solvents. Figure 3.5 shows that the inactive DMNPE hydrazone is soluble in all of the
solvents tested. The 355 nm peaks does show similar solubility in the different solvents.
Similar results were noted when the activated samples of DMNPE were scanned as can
be seen in Figure 3.6, and so this leads us to determine that DMNPE is adequately
soluble in all of the solvents studied.
Next, it was necessary to determine whether the DNA oligonucleotides would be
soluble in these solvents. The results of phosphodiester ODN samples are shown in
Figure 3.2. They demonstrated very little solubility in any of the solvents including DMF.
In Figure 3.3, it was observed that again very little solubility was noticeable in the
solvents, with the exceptions of DMF and slightly in methanol. At this point, methanol
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and acetonitrile were evaluated with mixtures of 33%, 50%, and 66% of each with water
and made from native phosphodiester and phosphorothioate ODN stocks. DMF
mixtures were also showed adequate solubility of the DNA oligonucleotides.
As shown in Figure 3.4 and Table 3.1, phosphodiester DNA ODNs showed
solubility in all of these mixtures for both solvents. This was also the case with the
phosphorothioate DNA ODN samples demonstrated in Table 3.1 as absorbance at 260
nm was very close for all samples. In the case of acetonitrile mixtures, the solvent was
extremely volatile, and thus some higher peaks at 260 nm for the higher percentage
acetonitrile solutions could be attributed to reduction in volumes by evaporation, which
lead to higher concentration solutions. Quick evaporation of the acetonitrile samples
was noted in more than one of the samples. However, a fairly consistent region of
peaks was observed in all samples, providing a solid starting ground for utilizing these
solvents to improve characterization of the caged oligonucleotides. The spectral
interference found with DMF is not found with any of the other solvents. Due to its high
absorbance of light at 260 nm, there is a reduction in the accuracy of the spectral scans
taken for the ODNs. This was not noted as an issue with the other solvents studied.
Table 3.3 below displays the solvents and their characteristics in several categories
including solubility of DNA in mixtures of solvents, solubility of cage compounds,
compatibility with filters, and spectral interference they may have.
One focal point for these solvents was their compatibility with the purification techniques
used. Isopropanol was initially eliminated with no solubility of DNA as expected.
Unfortunately, the high volatility of acetonitrile made it unsuitable with many of the
filtration systems. DMF in low percentages was compatible with the filters. Methanol,
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although seemingly compatible, was unable to adequately activate the DMNPE when
suspended entirely in methanol (Figures 3.13 and 3.14), nor was the caging reaction
itself very efficient when compared to that of DMF and DMSO. Figures 3.13 and 3.14
also demonstrate a greater restoration of activity for DMF when compared to DMSO.
DMF has a restoration of activity by 3.2 and 9.7-fold for PD-ODNs and PS-ODNs,
respectively, as compared to 2.7 and 3.8-fold restoration in DMSO samples. This
limitation lead to us to chose DMF as the solvent of choice with high reactivity of the
cage compound and ODNs in the solvent.
Table 3.3. Solvent Compatibility Comparison.
Solvent

DNA
Solubility

Cage
Solubility

Solubility Compatibility
260 nm
of caged
with filters
Spectral
DNA*
Interference
Water
+++
X
+
+++
+++
DMF*
+++
+++
+++
+
+
MeCN*
X
+++
+++
X
+++
MeOH*
+
+++
+++
+
+++
100% IPA
X
+++
X
X
+++
• * = Mixtures of solvent and water
• +++ = Compatible ++ = Moderate + = Slight X = Incompatible
We next focused on determining the optimum technique for purifying the samples
upon completion of the reaction. It is important to recall that prior to filtration, the
samples used were completely identical. Looking at the results of the purification
technique study, Figures 3.7 and 3.8 showed the spectral analysis of the samples after
they were purified. Figure 3.7 shows the spectral scan for the phosphodiester ODN
samples, with the highest absorbance at 260 nm attributed to the Microcon YM-3
molecular weight cut-off filters. This technique also, however, had the highest 365 nm
peak, which suggested the presence of excess unattached cage compound. This was
due to the lack of secondary washes, which were later performed. Upon completion of
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four additional washes of 33% DMF, excess caging compound was removed. The next
highest peak in this case was attributed to the sample run through the Sephadex G-25
column, while the lowest peak was ascribed to the dialysis sample. Complications with
the organic solvent mixture of DMF caused corrosion of the membrane of the Slide-aLyzer cassettes used to dialyze the sample. Compatibility of the DMF reaction with this
technique is unlikely to be very effective when used regularly.
In Figure 3.8, it was observed that in the case of phosphorothioate DNA ODNs,
the highest peak was again found with the Microcon YM-3 filters, however the Slide-aLyzer nearly matched it. The Sephadex filter had a very minute peak, and thus showed
a low ability to filter out this reaction when phosphorothioate DNA ODN is used. This
may be due to swelling or other alteration of the Sephadex matrix in the presence of
DMF. Looking at Table 3.2, the efficiencies of the samples follow a similar pattern. The
highest yield with phosphodiester DNA could be noted in the Microcon YM-3 filters.
Although it had the highest caging efficiency of the three methods, this was improved by
the multiple washes. Phosphorothioate samples presented the Slide-a-Lyzer unit as the
most efficient in DNA recovery and excess cage removal. This would likely have differed
if secondary washes were performed with the Microcon YM-3 filters. Cost also became
an issue when presented with the dialysis technique, as was the time required. The
cost of the Slide-a-lyzer technique cost more than four times that of the Microcon YM-3
filters, which also require approximately four hours to complete purification. This is
much shorter than the overnight dialysis process. The gel electrophoresis run for each
set of samples, seen in Figures 3.9 and 3.10, provided evidence that hybridization
control was attained through the caging reaction. The samples shown provided an
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insight into reduced mobility for caged samples along with reduced stain attachment.
Once exposed to UV-light of 365 nm in wavelength, increased mobility as well as
improved staining provides evidence of the control of hybridization. The molecular
beacon hybridizations in Figures 3.11 and 3.12 confirm the results attained from the gel
electrophoresis. Although hybridization was not very well restored in the
phosphorothioate samples, these samples were characterized as more heavily caged,
and so may have required longer exposure with the 365 nm light. Restoration of the
ability to hybridization is shown in Figure 3.11, where caged samples remained at low
levels, and were restored to nearly 4 times the relative fluorescence of the caged ODNs
once exposed to the 365 nm light.
Table 3.4. Purification Technique Comparison.
Purification
Technique
Microcon YM-3
G-25 Sephadex
Slide-a-Lyzer

Solvent
Compatibility
Yes
Yes
No

Volume of Reaction
filter can hold
500 µL
50 µL
500 µL

Cost
Low
High
Mid

Efficiency
of Recovery
High
Mid
Mid

Based on cost and the other factors, we can see in Table 3.4 below that the
Microcon YM-3 filters showed the most overall promise in the majority of the areas that
were rated of importance, even though they were not the best in the experiment with the
phosphorothioate samples. Recovery of the ODNs becomes of great importance when
phosphorothioate ODNs are used, as cost of the modified oligonucleotides is greatly
increased in comparison to the phosphodiester ODNs, and the most consistent DNA
recovery was shown in the Microcon YM-3 filters. The time factor was also important,
as the dialysis technique was run overnight in order to efficiently purify the samples.
Also, the Micron YM-3 filters had the capacity to work under the highest concentration of
DMF.
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The overall results of this study provide clarity in choosing a solvent in which to
run and characterize caging reactions. DMF has proven to be the most appropriate
solvent, and adequately oxidizes the DMNPE hydrazone precursor into the activate
diazoethane. Of the solvents, DMF was the most consistent at compatibility with the
purification methods, and allows for adequate spectral characterization. DMF also
seemed to have little complication with the chosen purification method of the Microcon
YM-3 filters. These filters provided adequate volume to purify an entire caging reaction,
as well as to be completed rapidly when compared to dialysis. Due to its low cost in
comparison to the other two techniques, the Microcon YM-3 filter also gives the highest
DNA recovery. This combination of solvent and purification technique was suitable for
this reaction and the subsequent molecular assays.
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Chapter 4
Conclusions and Future Considerations
Conclusions
The control of oligonucleotides has become an important focus in the
development of gene therapies. By controlling the ability for oligonucleotides to
hybridize, a more effective approach to using oligonucleotides for a multitude of
purposes can be developed. The purpose of this research was to develop a method to
control DNA oligonucleotides through the use of photo-cleavable cage compounds, thus
allowing for a spatial and temporal management of DNA. The presence of the attached
cage compound has been shown to block hybridization. The strategy was to provide a
simple, efficient method through which light could be used as a trigger for hybridization
activation. While the use of such control methods has been studied with mRNA and
DNA plasmids reacted with cage compounds, little in depth study has been placed on
DNA oligonucleotides (Ando 2001). We have demonstrated in several bioassays that
caging DNA oligonucleotides, both modified and unmodified, can block the DNA’s
capacity to hybridize. We were also able to show that once exposed to near UV-light,
restoration of hybridization is partially restored to the DNA oligonucleotides.
DNA oligonucleotides were reacted with the cage compound 1-(4,5-dimethoxy-2nitrophenyl)diazoethane (DMNPE) in order to temporarily block hybridization activity
that could later be restored with exposure to light. Spectrophotometry data
demonstrated that cage attachment had occurred during the reaction, and this was also
confirmed through the use of non-denaturing gel electrophoresis. Through the use of
molecular beacon hybridization assays, we were able to demonstrate that control of the
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caged DNA oligonucleotides functionality was evident. In our studies, the caged
oligonucleotides demonstrated less than 15% of the activity shown by the native (noncaged) oligonucleotides. Once exposed to light, these samples restored much of their
hybridization activity, reaching nearly 80% of that of the native oligonucleotide.
Qualitative analysis of these molecular beacon hybridizations were performed using
non-denaturing gel electrophoresis, and provided confirmation of the results attained
from the molecular beacon assays.
The utility of the cage compounds in controlling the hybridization activity of DNA
oligonucleotides was not limited to standard phosphodiester DNA oligonucleotides. The
caging method was shown to be more reactive with the modified phosphorothioate DNA
oligonucleotides, and reduced hybridization activity with even greater consistency than
with the phosphodiester oligonucleotides. Once again, this reaction was demonstrated
through the use of spectrophotometry, molecular beacon hybridization, and gel
electrophoresis assays. The more reactive phosphorothioate oligonucleotides
demonstrated much greater reduction in hybridization activity than that of the
phosphodiester oligonucleotides, although restoration of activity proved much less
efficient. This restoration did recover activity from caged values as low 2% to light
exposed values of 35% of the hybridization activity of the native oligonucleotide. This
was most likely attributed to the heavier caging, and thus may require exposure to light
for longer amounts of time or under more intense energy, as well as to a lower quantum
yield for DMNPE caging of a target when sulfur modifications are present (Walker
1988).
Solvent and purification technique studies provided optimization of the caging

68

reaction and the purifications of samples. N,N-dimethylformamide (DMF) was retained
as the solvent used in the caging reactions of the ODN. It provided the most effective
caging, while also allowing for adequate and proper purification. Although the spectral
interference caused by the absorbance of light by DMF from 200 to 260 nm provided
some concern, the benefits provided from using the solvent greatly outweighed this
drawback. Use of Microcon YM-3 filters provided the optimal purification of the ODNs in
comparison to the other techniques studied. With the addition of secondary washes to
the filtration process, optimal purification of the caged ODNs was achieved.
In an effort to develop greater sensitivity in the molecular beacon assays,
experiments were run to help provide a more accurate understanding of the
hybridization ability of caged and caged-flashed oligonucleotides at various
temperatures. Applications of this study could help to provide a better understanding of
the likelihood of improper hybridization in vivo. These oligonucleotides were also run in
comparison to base mismatched oligonucleotides, which have previously been shown to
have differing hybridization activity at varying temperatures (Bonnet 1999; Tsourkas
2002; Tsourkas 2003). The study demonstrated that there is little effect of temperature
on the hybridization activity of caged and caged-flashed oligonucleotides when
compared to the native and base mismatched samples.
In conclusion, the data presented has shown that the use of cage compounds
can provide a photo-cleavable method for spatial and temporal control the hybridization
activity of oligonucleotides. This also provides a strategy for future application of this
strategy as a tool in providing targeted antisense and RNAi drug delivery and
application.
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Future Considerations
Findings of this project showing the ability to photo-control DNA oligonucleotide
hybridization activity through the use of the cage compound DMNPE provide great
promise for future development of cage compounds with respect to genetic therapy.
The use of cage compounds can differ for each individual study, however several other
cage compounds other than DMNPE have been used with DNA and RNA. 6-bromo-7hydroxycoumarin-4-ylmethly (BHC) was used by Ando to cage mRNA in zebrafish
embryos (Ando 2001). Use of other caging compounds such as 4,5-Dimethoxy-2nitrobenzyl bromide (DMNB) may provide a less expensive technique for achieving
similar results to those seen with DMNPE. DMNB has previously been demonstrated to
cage hydroxyls on β-ecdysone and estradiol as a means to control gene expression
(Cruz 2000; Lin 2002). It may provide another, possibly more efficient, method for
achieving spatial and temporal control of DNA oligonucleotides.
Further studies into purification techniques of the samples may also prove
beneficial to future research. The issue of solvent compatibility has lead to much
concern when dealing with cage compounds that are minimally soluble in water, and
thus can cause issues. By developing more improved purification techniques and
protocols, better knowledge of the caging method can be achieved. Initial studies
shown in chapter showed that filtration of caged samples once exposed to light, helped
to remove the released cage molecule and prevent any interference with the assays.
Scavenger compounds such as dithriothreitol (DTT) are another possible technique that
could bind the released nitrosoketone and prevent it from causing any interaction
problems for hybridization. DTT is also permeable to cell membranes, and thus could
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be an important tool when caging is used with antisense technologies. Functional
separation of the caged oligonucleotides from the non-caged oligonucleotides remaining
in the samples could also help improve efficiency as well as reduce leakage in the case
of antisense oligonucleotides. One technique that could be used would be attachment
of ODNs complementary to our caged ODN. By hybridizing with the non-caged ODNs
in the solution, the ODNs attached to the beads may functionally separate the caged
oligonucleotides, thus reducing the risk of non-caged oligonucleotides interfering with
assays or possibly causing leakage in antisense activity prior to light exposure if in vivo.
Currently, the caging reaction is performed with random attachment of DMNPE to
the target oligonucleotides, and thus leads to increased and varied amounts of cage
compound attached to the target, and requiring greater light-exposure in order to restore
activity. Studies of base mismatch location provide insight onto a method to account for
this, and improve the efficiency of the caging of oligonucleotides, and minimizing the
light exposure required. Studies by Bonnet indicated that the location of base
mismatches along an oligonucleotide affected the ability for the oligonucleotide to
hybridize, especially noted at 37ºC, which is the standard temperature within a healthy
cell (Bonnet 1999). By synthesizing the oligonucleotides with cage compounds in
specific sites along the sequence, the effectiveness of this control method could be
greatly augmented. By determining the most appropriate attachment sites for the cage
compound along the specific sequence in question, improved photo-restoration of
hybridization can be achieved. This can become extremely important if used for
antisense therapies, as less exposure of cells and tissue to UV-light reduce the risks of
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cell damage. Use of two-photon photolysis as described in chapter 1 can also be used
as a means to reduce risk of cellular damage.
Improved molecular assays for determining the effects of cage compounds on
oligonucleotides would also be of great benefit to future studies of the use of cage
compounds to control ODNs. By improving molecular beacon assays through
temperature variation, greater sensitivity can be used to verify the effectiveness of a
cage compound in controlling hybridization activity. Studies focusing on other
phosphate backbone and base modifications along an oligonucleotide could provide an
insight on ways to improve this technology. This would also help to possibly provide
further understanding and confirmation of the location of attachment of the cage
compound when reacted with nucleic acids. It could also confirm the effectiveness of
the temperature varying molecular beacon hybridization to properly represent the
abilities of the cage compounds.
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Appendix A: Molecular Beacon Temperature Assays
Introduction
The sensitivity of molecular beacons to their targets has been a new area of
interest in the field. Several studies have demonstrated how accurately the molecular
beacons would be able to distinguish their target from other similar sequences,
including those with only a single base alteration (Tyagi 1998). Shorter loop regions
show more interference with a single base mismatch on hybridization (Aboul-ela 1985).
This specificity is affected by several conditions including pH, salt concentration, and
temperature. Looking at temperature, several studies have demonstrated an increase
in mismatch discrimination of the molecular when temperature is increased to certain
levels (Bonnet 1999; Tsourkas 2002; Tsourkas 2003). These studies showed
significant decreases in the hybridization of beacon with targets with as little as a single
base mismatch, leading to the belief that other modifications to the oligonucleotide may
have a similar result.
In this study we focus on the effects of temperature on caged and caged-flashed
ODNs and their ability to hybridize with molecular beacons. This would also be in
comparison with the perfect or native target, as well as two other modified ODNs, one
with a single base mismatch and the other with two base mismatches. In order to
determine the variable specificity of the molecular beacon assay with respect to caged
and caged flashed ODNs, it was important to look at effects of temperature on the
caged samples themselves, and compare the results to those retained through standard
beacon hybridizations.
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Materials & Methods
Sample Preparation
As was described in chapter 2, samples were prepared similarly in this study.
Samples of caged ODNs (ISIS 2302) were prepared using the same protocol as found
in Appendix A, and purified using the Microcon YM-3 filters as shown in Appendix B with
4 secondary washes.

After characterization, the caged samples, along with native

20mer ODNs (GCCCAAGCTGGCATCCGTCA), a 20-mer single mismatch ODN (T-MM:
GCCCAAGCTTGCATCCGTCA)

and

a

20-mer

two

mismatch

ODN

(TT-MM:

GCCCAAGCTTTCATCCGTCA) were all diluted to 400 µL working stocks with a
concentration of 0.05 µg/µL. 200 µL of the caged sample was then exposed to UV-light
(365 nm) for 20 minutes and filtered with the Microcon YM-3 filter protocol and
resuspended back to µL.
Once prepared the working stocks were then run through molecular beacon
hybridization. For each sample, the ODNs were prepared as performed with a 5:1
molar ratio of target to molecular beacon as follows: 0.305 µg of native (non-caged),
caged, caged-flashed, T-MM, TT-MM target ODN were each mixed with 0.105 µg of
complementary molecular beacon in 500 µL solutions of 100 mM NaCl, 1mM EDTA, pH
7.5. One sample containing only 0.105 µg of molecular beacon was also prepared in
identical buffers and brought up to 500 µL. A seventh solution containing 0.085 µg of a
5’FAM modified 20-mer ODN identical in sequence to the native was also prepared
following the same protocol and used as a control.
Hybridization Reaction and Fluorescence Detection
100 µL of each of the mixtures was then denatured at 90°C for 5 min and allowed to
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slowly cool to 25°C over 60 min. Fluorescence of hybridization solutions was used to
quantify the hybridization of molecular beacons with ODNs. Each of the 100 µL
hybridization mixtures was excited at 492nm and emitted fluorescence quantified at
515nm in triplicate with a LS55B Luminescence Spectrophotometer (Perkin Elmer,
Wellesley, MA).
300 µL from each of the stocks was then placed in 100 µL aliquots into separate
wells of a 96-well plate and run on an iCycler thermal cycling unit IQ Optical System
(Bio-Rad Laboratories, Hercules, CA). Samples were initially brought up to 95 °C and
held there for 5 minutes, at which point the temperature was decreased 1°C every
minute until the final temperature of 25 °C was achieved. As temperature decreased,
fluorescence readings of all samples were taken for each one °C. The wavelengths of
light used by the optical system were 488 nm for excitation and 515 nm for emission
detection. Samples were initially calibrated dynamically by the iCycler system at 95 °C.
For dynamic calibration, samples were initially cycled between 60 °C and 95 °C several
times to ensure that any duplexes would be denatured, at which point the system
remained at 95 °C and took readings from each sample and normalized their
fluorescence at 95 °C.
Results
Looking at the fluorescence readings shown in Figure A.1, differing amounts of
hybridization are seen between the several target ODNs. The relative fluorescence for
the molecular beacon alone in this experiment has a relatively high fluorescence at 38.9
RFUs. It is not very distinct from that of the native as was the case in the experiment
shown in chapters 2 and 3. The native ODN has a relative fluorescence of 92.0 RFUs,
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while the single mismatch ODN (T-MM) has a nearly identical reading at 90.4 RFUs or
97.0% of native. This does slightly decrease for the two mismatch ODN (TT-MM) with a
value of 74.5 RFUs or 67.2% of native ODN when background noise is subtracted. The
caged sample had a value of 40.2 RFUs (9.18% of native) that is indicative of effective
caging, and was restored to 62.1 RFUs (43.7% of native). The FAM-labeled ODN
showed the highest fluorescence at 144 RFUs, which is expected since no quencher is
present in the solution.
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Figure A.1. Relative fluorescence intensities from solutions of molecular
beacon hybridized with native, single mismatch (T-MM), two mismatch (TTMM), caged or caged-light-exposed ODNs. Molecular beacon alone and the
FAM ODN are both used as controls.
Relative fluorescence readings are shown in Figure C.2 for the samples at
various temperatures and the effects of temperature change on the target ODNs.
Molecular beacon alone follows its standard path at a value of 1449 RFUs at 25°C and
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slowly increasing to 3198 RFUs at 95°C. The native ODN resulted in the highest
fluorescence slowly increasing until peaked at 4014 RFUs at 54°C, and then returning
to a similar 95°C value as that of molecular beacon alone. Similarly the single base
mismatch ODN (T-MM) a slight increase from 25°C peaking at 3078 RFUs at 41°C,
while the two base mismatch ODN (TT-MM) began to immediately decline from its 25°C
fluorescence value of 2002 RFUs. For the caged and caged-flashed samples little
change occurred from the 25°C values of 1163 and 2010 RFUs, respectively and then
both following the molecular beacon alone trend after 45°C. The FAM ODN had a
unique trend of steadily escalating in fluorescence as temperature increases from 25°C
(2458 RFUs) to 95°C (3323 RFUs). All of the samples showed a similar amount of
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Figure C.2. Temperature varied relative fluorescence intensities from
solutions of molecular beacon hybridized with native, single mismatch (TMM), two mismatch (TT-MM), caged or caged-light-exposed ODNs.
Molecular beacon alone and the FAM ODN are both used as controls.
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fluorescence at 95°C due to the dynamic normalization run by the iCycler system prior
to the performance of readings.
Discussion
The data from this study suggest that the effects of temperature on the
discriminating ability of molecular beacons are dependent on the type of modification of
the native ODN. In the case of the room temperature assays seen in Figure A.1, very
little difference existed between native ODN and the single base mismatch ODN. The
fluorescence slightly lowers as the number of base matches increased to two, as seen
in the two base mismatch ODN, dropping from 96.97% of native in the single mismatch
(T-MM) ODN to 67.15% of native for the double mismatch (TT-MM) ODN. The caged
ODNs followed expected patterns by reducing hybridization to 9.18% of native, and
once photo-exposed returning up to 43.73% of native fluorescence. This demonstrates
that caging has a much greater affect on reducing hybridization ability than does a one
or two base mismatch.
Temperature effects on the ability of these ODNs to hybridize followed previously
reported findings. Effects of temperature on the mismatched ODNs versus that of the
native ODN showed very similar results to studies performed by Tsourkas and Bonnet
(Bonnet 1999; Tsourkas 2002; Tsourkas 2003). As the temperature increased from
25°C, characteristic decreases in the base mismatch ODNs could be seen. Initially, TTMM ODN began to reduce as soon as the temperature was greater than 25°C. The TMM ODN similarly followed this pattern, however its peak was noted at 41°C, prior to its
decrease in fluorescence. In comparison to the native ODN, increases in the number of
base mismatches lead to lower melting temperatures for the hybridized duplex of the
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ODN and molecular beacon, as was seen in previous studies (Bonnet 1999). The
native ODN reached its peak fluorescence at 54°C, thus providing an optimum
temperature range of 52°C to 57°C at which to take readings for the most favorable
discrimination between samples containing perfect target and single base mismatched
target.
In the case of the caged and caged-flashed ODNs, very little change was noticed
based on temperature outside of the behavior of the beacon alone. The caged sample
remained below that of the molecular beacon alone at room temperature, and did not
increase in fluorescence substantially until the temperature was greater that 45°C. The
case was similar for the caged-flashed ODN, which although much higher at room
temperature than the molecular beacon alone, there was little increase until this 45°C
point. In comparison to native, these two samples were much lower in fluorescence,
and increases in temperature showed little increase in the sensitivity of the molecular
beacon with respect to caged samples. This is possibly due to the modification of the
backbone theorized to take place in caging, as opposed to the base modifications seen
in base mismatched ODNs. In modifying the backbone, increased suppression may be
attainable, however hybridization of these caged samples may not be affected by
temperature as is the case with the FAM ODN, which has much less fluctuation with
varying temperature showing little effect of temperature on the fluorophore itself.
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Appendix B: Caging Protocol for ODN DNA
a. Activate DMNPE:
In a plastic weigh boat, weigh approximately:
5 mg 4,5-dimethoxy-2-nitroacetophenone hydrazone (yellow crystals,
stored at –20 °C)
50 mg Manganese (IV) oxide (black pellets, stored at 25 °C )
Transfer to a 1.5 ml eppendorf and wash in 1 ml DMSO (clear viscous
liquid, stored at 25 °C). Protect the eppendorf from light from this point
onwards by shielding it with aluminum foil. Vortex the solution for 15 sec.,
then rock on a NutatorTM for 20 min.
Before filtering, microfuge the solution for 30 sec. to draw large particles of
MnO2 to the bottom of the tube to prevent filter clogging. Solution should
look murky and dark reddish-brown.
b. Filter MnO2 from activated DMNPE:
a) Pack a 1 cc syringe with glass wool
b) Add 100 mg of CeliteTM diatomaceous earth (use a syringe w/
stopper removed to poke the glass wool & Celite to the bottom.)
c) Pre-wet the filter with 1 ml DMSO
d) Remove the top 900 µl of microfuged cage solution and gently
push through filter. Effluent should be a clearer red solution.
e) Microfuge this solution as well for 30 sec to ensure that any MnO2
that possibly passed through the filter will not be added to the
caging reaction (MnO2 will oxidize DNA as well.)
c. Prepare DNA and add activated cage:
a) ODNs were kept in either 10 mM Bis-Tris or HPLC Grade water.
For a reaction, 100 µg of DNA is brought up to 200 µl of 10 mM
Bis-Tris in a 1.5 ml eppendorf. 100 µl of the activated cage
solution is then added, vortexed briefly, and then put in an agitator
for 24 hrs at 4 °C.
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Appendix C: Purification Techniques
I. Sephadex Spin Columns
b. Dry down reaction volume(s) in vacufuge until precipitate forms (can take
several hours, however DMF is volatile enough to be removed.
c. Resuspend the sample into 100 µL of 0.2 µm-filtered water.
d. Column preparation
i.

Flick tube or vortex for a few moments to try and spread buffer
through out column.

ii.

To prevent a vacuum, first remove cap of column, then snap off
bottom tip.

iii.

Place column(s) into clean, empty 1.5 mL Eppendorf tubes and
place in microcentrifuge for 75 seconds at 1000 x g. Ensure that
chipped edge of columns all face towards center of microfuge.

iv.

Discard buffer solution in eppendorf and run 300 µL of 0.2 µm
filtered water through the column and place in micro centrifuge for
3 minutes at 1000 x g.

v.

Remove tube and place column into a new, sterile 1.5 mL
Eppendorf tube.

II. Slide-a-Lyzer Dialysis
a. Hydrate Membrane
i. Remove Slide-A-Lyzer® Cassette from its pouch and slip into the
groove of an appropriate size buoy.
ii. Immerse cassette in dialysis buffer for 30 seconds.
iii. Remove cassette from buffer and remove excess liquid by tapping
the edge of the cassette gently on paper towels.
b. Add Sample
i. fill the syringe with the sample, leaving a small amount of air in the
syringe.
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ii. With the bevel sideways, insert the tip of the needle through one of
the syringe ports located at a top corner of the cassette.
iii. Inject sample slowly. Withdraw air by pulling up on the syringe
piston.
iv. Remove the syringe needle from the cassette while retaining air in
the syringe.
c. Dialyze
i. Slip the cassette into the groove of the buoy and float this assembly
in 300 mL of the dialysis solution of 33% DMF.
ii. Leave in Dialysis solution at room temperature at room temperature
for 4 hours.
iii. Change the dialysis buffer solution and let dialyze for another 4
hours at room temperature.
iv. Change the dialysis buffer solution and let dialyze overnight at 4 °C.
d. Remove Sample
i. Fill the syringe with a volume of air equal to the sample size and,
with the bevel sideways, insert the tip of the needle through another
syringe port located at a corner of the cassette.
ii. Inject air slowly into the cassette to separate the membranes.
iii. Turn the unit so that needle is on the bottom and allow the sample
to collect near the port. Withdraw the sample into the syringe.
III. Microcon YM-3 Molecular Weight Cut-off Filters
a. Remove a filter and accompanying 1.5 mL centrifuge tube. Place filter
properly in tube.
b. Place up to 500 uL of sample into the filter, seal cap, and place into
microcentrifuge.
i. Be sure to counterbalance the weight of the tube, filter, and sample
once in the centrifuge.
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c. Spin sample at maximum speed (13,400 RPMS, approximately 12,000
g’s) for 90 minutes at room temperature.
d. Once complete, add 100 uL of 33% DMF solution to wash sample, and
spin again for 30 minutes.
e. Repeat step “d” three more times.
f. Once complete, flip over the filter and place into a new fresh centrifuge
tube, and spin in centrifuge at 1000 g’s for 3 minutes.
g. Once complete, remove filter and discard. Keep centrifuge tube with newly
filtered product solution.
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